Regulatory toxicology and pharmacology

Regulatory Toxicology and Pharmacology

Volumn 35, Issue 2 II, 2002, Pages

  Butchko, Harriett H ^a   Stargel, W Wayne ^a   Comer, C Phil ^b   Mayhew, Dale A ^a   Benninger, Christian ^c   Blackburn, George L ^d   De Sonneville, Leo M J ^e   Geha, Raif S ^d   Hertelendy, Zsolt ^f   Koestner, Adalbert ^g   Leon, Arthur S ^h,i   Liepa, George U ^j   McMartin, Kenneth E ^k   Mendenhall, Charles L ^l   Munro, Ian C ^m   Novotny, Edward J ⁿ   Renwick, Andrew G ^o   Schiffman, Susan S ^p   Schomer, Donald L ^d   Shaywitz, Bennett A ⁿ   Spiers, Paul A ^q   Tephly, Thomas R ^r   Thomas, John A ^s   Trefz, Friedrich K ^t   more..

^a NutraSweet Company   (United States)

^b Graystone Associates Inc ^*  (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

^d HARVARD MEDICAL SCHOOL   (United States)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f UNIVERSITY OF CINCINNATI   (United States)

^g OHIO STATE UNIVERSITY   (United States)

^h UNIVERSITY OF MINNESOTA   (United States)

ⁱ UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^j EASTERN MICHIGAN UNIVERSITY   (United States)

^k LOUISIANA STATE UNIV MEDICAL CENTER   (United States)

^l VETERANS AFFAIRS MEDICAL CENTER   (United States)

^m Cantox Health Sciences International   (Canada)

ⁿ YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^o UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^p DUKE UNIVERSITY MEDICAL CENTER   (United States)

^q BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^r UNIVERSITY OF IOWA   (United States)

^s Mays Cancer Center at UT Health San Antonio   (United States)

^t UNIVERSITY OF TÜBINGEN   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; ASPARTAME; ASPARTIC ACID; METHANOL; PHENYLALANINE; SWEETENING AGENT;

ADOLESCENT; ADULT; ALLERGY; APPETITE; BEHAVIOR DISORDER; BODY WEIGHT; BRAIN TUMOR; CHILD; COGNITION; DIABETES MELLITUS; DISEASE ASSOCIATION; FOOD INTAKE; HEADACHE; HUMAN; INFANT; LACTATION; METABOLISM; MOOD; NEUROCHEMISTRY; NONHUMAN; OBESITY; PHENYLKETONURIA; POSTMARKETING SURVEILLANCE; PRIORITY JOURNAL; REVIEW; SAFETY; SEIZURE;

ANIMALIA;

EID: 18744379772     PISSN: 02732300     EISSN: None     Source Type: Journal    
DOI: 10.1006/rtph.2002.1542     Document Type: Article

References (560)

1. J.A. Bantle D.J. Fort J.R. Rayburn D.J. DeYoung S.J. Bush Further validation of FETAX: Evaluation of the developmental toxicity of five known mammalian teratogens and non-teratogens Drug Chem. Toxicol. 13 1990 267 282
2. R.L. Brunner C.V. Vorhees L. Kinney R.E. Butcher Aspartame: assessment of development psychotoxicity in a new artificial sweetener Neurobehav. Toxicol. 1 1979 79 86
3. S.L. Burgert D.W. Andersen L.D. Stegink H. Takeuchi H.P. Schedl Metabolism of aspartame and its L -phenylalanine methyl ester decomposition product by the porcine gut Metabolism 40 1991 612 618
4. D.L. Dow-Edwards L.A. Scribani E.P. Riley Impaired performance on odor-aversion testing following prenatal aspartame exposure in the guinea pig Neurotoxicol. Teratol. 11 1989 413 416
5. A.D. Durnev A.V. Oreshchenko A.V. Kulakova N.F. Beresten S.B. Seredenin Clastogenic activity of dietary sugar substitutes Vopr. Med. Khim. 41 1995 31 33
6. Fed. Regist. 39 1974 27317 27320
7. Food and Drug Administration (FDA)1981. Aspartame: Commissioner's final decision. Fed. Regist.46, 38285–38308. July 24, 1981.
8. Fed. Regist. 48 1983 31376 31382
9. Fed. Regist. 49 1984 6672 6677
10. Fed. Regist. 63 1998 16417 16433
11. Proposal on Aspartame 1979 Health Protection Branch Ottawa
12. Health and Welfare Canada, 1981, Aspartame, Information Letter No. 602. Health Protection Branch, Ottawa, July 31, 1981.
13. M.D. Holder Effects of perinatal exposure to aspartame on rat pups Neurotoxicol. Teratol. 11 1989 1 6
14. Ishii, H.1984. Chronic feeding studies with aspartame and its diketopiperazine. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 307–319. Marcel Dekker, New York.
15. WHO Food Additive Series No. 15 1980 JECFA Geneva p. 18–86
16. WHO Food Additive Series No. 28 1991 JECFA Geneva p. 219–228
17. A.M. Jeffrey G.M. Williams Lack of DNA-damaging activity of five non-nutritive sweeteners in the rat hepatocyte/DNA repair assay Food Chem. Toxicol. 38 2000 335 338
18. G.A. Karikas K.H. Schulpis G. Reclos G. Kokotos Measurement of molecular interaction of aspartame and its metabolites with DNA Clin. Biochem. 31 1998 405 407
19. A. Kasamaki S. Urasawa The effect of food chemicals on cell aging of human diploid cells in in vitro culture J. Toxicol. Sci. 18 1993 143 153
20. Kotsonis, F. N., and Hjelle, J. J.1996. The safety assessment of aspartame: Scientific and regulatory considerations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 23–41. CRC Press, Boca Raton, FL.
21. A.V. Kulakova E.G. Belogolovskaya A.V. Oreshchenko A.D. Durnev S.B. Seredenin The antimutagenic activity of aspartame Eksp. Klin. Farmakol. 62 1999 48 50
22. M.P. Mahalik R.F. Gautieri Reflex responsiveness of CF-1 mouse neonates following maternal aspartame exposure Res. Commun. Psychol. Psychiatry Behav. 9 1984 385 403
23. McAnulty, P. A, Collier, M. J, Comer, C. P, and, Allen, J. L. 1992, The Odour Aversion Technique Claimed to Demonstrate Effects of Aspartame in Guinea Pigs is Non-reproducible, Presented at the 32nd annual meeting of the, Teratology Society, Boca Raton, FL, June 1992.
24. P.A. McAnulty M.J. Collier J.M. Enticott J.M. Tesh D.A. Mayhew C.P. Comer J.J. Hjelle F.N. Kotsonis Absence of developmental effects of CF-1 mice exposed to aspartame in utero Fundam. Appl. Toxicol. 13 1989 296 302
25. Ministry of Agriculture Fisheries, and Food (MAFF), 1982, Food Additives and Contaminants Committee Report on the Review of Sweeteners in Food. Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment. FAC/REP/34:HMSO, 1982, United Kingdom.
26. Molinary, S. V.1984. Preclinical studies of aspartame in nonprimate animals. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 289–306. Marcel Dekker, New York.
27. M. Mukhopadhyay A. Mukherjee J. Chakrabarti In vivo cytogenetic studies on blends of aspartame and acesulfame-K Food Chem. Toxicol. 38 2000 75 77
28. R.E. Ranney J.A. Oppermann A review of metabolism of the aspartyl moiety of aspartame in experimental animals and man J. Environ. Pathol. Toxicol. 2 1979 979 985
29. K.H. Schulpis G.A. Karikas G. Kokotos Direct molecular interaction of phenylalanine with DNA measured by reversed-phase HPLC Clin. Chem. 44 1998 178 179
30. Scientific Committee for Food (SCF), 1985, Food-Science and Techniques , Reports of the Scientific Committee for Food, sixteenth series, Commission of the European Communities, Luxembourg.
31. R. Yirmiya E.D. Levin C.D. Chapman J. Garcia Morphological and behavioral effects of perinatal exposure to aspartame (Nutrasweet) on rat pups Bull. Psychon. Soc. 27 1989 153 156
32. Abrams, I. J. 1986, Using the menu census survey to estimate dietary intake: Postmarket surveillance of aspartame. In, International Aspartame Workshop Proceedings, November 17–21, 1986, Marbella, Spain, International Life Sciences Institute–Nutrition Foundation, Washington, DC.
33. Abrams, I. J.1992. Using the menu census survey to estimate dietary intake: Postmarket surveillance of aspartame. In Food Safety AssessmentJ. W. Finley, S. F. Robinson, and D. J. Armstrong, Eds., pp. 201–213. Am. Chem. Soc., Washington, DC.
34. A. Bar C. Biermann Intake of intense sweeteners in Germany Z. Ernahrungswiss. 31 1992 25 39
35. Bergsten, C. 1993, Intake of Acesulfame-k, Aspartame, Cyclamate, and Saccharin in Norway , SNT Report 3, Norwegian Food Control Authority, Oslo, Norway.
36. H. Butchko Response to “Calculation of aspartame intake in children by Thomas-Doberson” (letter) J. Am. Diet. Assoc. 90 1990 360 361
37. H.H. Butchko F.N. Kotsonis Aspartame: Review of recent research Comments Toxicol. 3 1989 253 278
38. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
39. Butchko, H. H., and Kotsonis, F. N.1994. Postmarketing surveillance in the food industry: the aspartame case study. In Nutritional ToxicologyF. N. Kotsonis, M. Mackey, and J. Hjelle, Eds., pp. 235–250. Raven Press, New York.
40. Butchko, H. H., and Kotsonis, F. N.1996. Acceptable daily intake and estimation of consumption. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 43–53. CRC Press, Boca Raton, FL.
41. H.H. Butchko C. Tschanz F.N. Kotsonis Postmarketing surveillance of food additives Regul. Toxicol. Pharmacol. 20 1994 105 118
42. Butchko, H. H., Stargel, W. W., Comer, C. P., Mayhew, D. A., and Andress, S.2001. Aspartame. In Alternative SweetenersL. Nabors, Ed., 3rd ed., pp. 41–61. Marcel Dekker, New York.
43. H.H. Butchko W.W. Stargel Aspartame: Scientific evaluation in the postmarketing period Regul. Toxicol. Pharmacol. 34 2001 221 233
44. Butchko, H. H., and Stargel, W. W.2002. Postmarketing surveillance in the food industry: The aspartame case study. In Nutritional ToxicologyF. N. Kotsonis and M. Mackey, Eds., second ed., pp. 287–315. Taylor & Francis, London/New York.
45. M. Chambolle A. Collerie de Borely C. Renault J. Volatier Intake of Intense Sweeteners in France (1989–1992). 1994 CREDOC, Departement Prospective de la Consommation Paris
46. J. Endres Response to “Calculation of aspartame intake in children by Thomas-Doberson” (letter) J. Am. Diet. Assoc. 90 1990 360
47. Fed. Regist. 39 1974 27317 27320
48. Fed. Regist. 46 1981 38285 38308
49. Fed. Regist. 48 1983 31376 31382
50. Fed. Regist. 49 1984 6672 6682
51. Fed. Regist. 51 1986 42999 43000
52. I. Garnier-Sagne J.C. Leblanc P. Verger Calculation of the intake of three intense sweeteners in young insulin-dependent diabetics Food Chem. Toxicol. 39 2001 745 749
53. Health and Welfare Canada, 1979, Proposal on Aspartame , Information Letter No. 564, Health Protection Branch, Ottawa.
54. Heybach, J. P., and Allen, S. S.1988. Resources for inferential estimates of aspartame intake in the United States. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 365–372. Birkhauser, Boston.
55. J.P. Heybach J.L. Smith Intake of aspartame in 19–50 year old women from the USDA continuing survey of food intakes by individuals (CSFII 85) FASEB J. 2 1988 A1615
56. J. Heybach C. Ross Aspartame consumption in a representative sample of Canadians J. Can. Diet. Assoc. 50 1989 166 170
57. A.L. Hinson W.M. Nicol Monitoring sweetener consumption in Great Britain Food Addit. Contam. 9 1992 669 680
58. Hulshof, K. F. A. M, and, Bouman, M. 1995, Use of Various Types of Sweeteners in Different Population Groups: 1992 Dutch National Food Consumption Survey , TNO Nutrition and Food Research Institute, Netherlands.
59. WHO Food Additive Series No. 15 1980 18 86
60. C. Leclercq D. Berardi M.R. Sorbillo J. Lambe Intake of saccharin, aspartame, acesulfame K and cyclamate in Italian teenagers: Present levels and projections Food Addit. Contam. 16 1999 99 109
61. Ministry of Agriculture Fisheries, and Food (MAFF), 1990, Intakes of intense and bulk sweeteners in the UK 1987–1988 , Food Surveillance Paper No. 29, Ministry of Agriculture, Fisheries and Food, London, UK.
62. Ministry of Agriculture Fisheries, and Food (MAFF), 1995, Survey of the Intake of Sweeteners by Diabetics , Food Surveillance Info. Sheet. Ministry of Agriculture, Fisheries and Food, Food Safety Directorate, London, UK.
63. National Food Authority Australia, 1995, Survey of Intense Sweetener Consumption in Australia: Final Report , Canberra, Australia.
64. Reports of the Scientific Committee for Food, sixteenth series 1985
65. Stegink, L. D.1984. Aspartame metabolism in humans: Acute dosing studies. In Aspartame: Physiology and Biochemistry.L. D. Stegink and L. J. Filer, Jr., Eds., pp. 509–553. Marcel Dekker, New York.
66. T.E. Stenzel Response to “Calculation of aspartame intake in children by Thomas-Doberson” (letter) J. Am. Diet. Assoc. 90 1990 360
67. D. Thomas-Doberson Calculation of aspartame intake in children J. Am. Diet. Assoc. 89 1989 831 833
68. D. Thomas-Doberson Calculation of aspartame intake in children (letter) J. Am. Diet. Assoc. 90 1990 362, 364
69. M.C.F. Toledo S.H. Ioshi Potential intake of intense sweeteners in Brazil Food Addit. Contam. 12 1995 799 808
70. S.M. Virtanen L. Rasanen A. Paganus P. Varo H.K. Akerblom Intake of sugars and artificial sweeteners by adolescent diabetics Nutr. Rep. Int. 38 1988 1211 1218
71. S.L. Burgert D.W. Andersen L.D. Stegink H. Takeuchi H.P. Schedl Metabolism of aspartame and its L -phenylalanine methyl ester decomposition product by the porcine gut Metabolism 40 1991 612 618
72. T.S. Burns W.W. Stargel A. Hurwitz Bioavailability of phenylalanine and aspartate from aspartame (20 mg/kg) in capsules and solution Metabolism 39 1990 1200 1203
73. T.S. Burns W.W. Stargel C. Tschanz F.N. Kotsonis A. Hurwitz Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino-acid ratio in healthy-subjects Pharmacology 43 1991 210 219
74. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
75. Butchko, H. H., and Kotsonis, F. N.1996. Acceptable daily intake and estimation of consumption. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 43–53. CRC Press, Boca Raton, FL.
76. B. Caballero B.E. Mahon F.J. Rohr H.L. Levy R.J. Wurtman Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria J. Pediatr. 109 1986 668 671
77. H. Curtius W. Endres N. Blau Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria Metabolism 43 1994 413 416
78. J.D. Fernstrom R.J. Wurtman B. Hammarstrom-Wiklund W.M. Rand H.N. Munro C.S. Davidson Diurnal variations in plasma concentrations of tryptophan, tyrosine and other neutral amino acids: Effect of dietary protein intake Am. J. Clin. Nutr. 32 1979 1912 1922
79. L.J. Filer Jr. G.L. Baker L.D. Stegink Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants J. Nutr. 113 1983 1591 1599
80. Filer, L. J. Jr., Baker, G. L., and Stegink, L. D.1984. Aspartame ingestion by human infants. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 579–591. Marcel Dekker, New York.
81. Filer, L. J. Jr., and Stegink, L. D.1988. Effect of aspartame on plasma phenylalanine concentration in humans. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 18–40. Birkhauser, Boston, MA.
82. L.J. Filer Jr. L.D. Stegink Aspartame metabolism in normal adults, phenylketonuric heterozygotes, and diabetic subjects Diabetes Care 12 1989 67 74
83. G.H. Frey Use of aspartame by apparently healthy children and adolescents J. Toxicol. Environ. Health 2 1976 401 415
84. N.M. Hooper R.J. Hesp S. Tieku Metabolism of aspartame by human and pig intestinal microvillar peptidases Biochem. J. 298 1994 635 639
85. Karim, A., and Burns, T.1996. Metabolism and pharmacokinetics of radiolabeled aspartame in normal subjects. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 57–66. CRC Press, Boca Raton, FL.
86. R.H. Knopp K. Brandt R.A. Arky Effects of aspartame in young persons during weight reduction J. Toxicol. Environ. Health 2 1976 417 428
87. R. Koch K.N.F. Shaw M. Williamson M. Haber Use of aspartame in phenylketonuric heterozygous adults J. Toxicol. Environ. Health 2 1976 453 457
88. Kotsonis, F. N., and Hjelle, J. J.1996. The safety assessment of aspartame: Scientific and regulatory considerations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 23–41. CRC Press, Boca Raton, FL.
89. A.S. Leon D.B. Hunninghake C. Bell D.K. Rassin T.R. Tephly Safety of long-term large doses of aspartame Arch. Intern. Med. 149 1989 2318 2324
90. W.E. Lipton Y.-N. Li M.K. Younoszai L.D. Stegink Intestinal absorption of aspartame decomposition products in adult rats Metabolism 40 1991 1337 1345
91. S.A. Mackey C.M. Berlin Jr. Effect of dietary aspartame on plasma concentrations of phenylalanine and tyrosine in normal and homozygous phenylketonuric patients Clin. Pediatr. 31 1992 394 399
92. Pan R. Martin-Du C. Mauron B. Glaeser R.J. Wurtman Effect of various oral glucose doses on plasma neutral amino acid levels Metabolism 31 1982 937 943
93. J.A. Oppermann E. Muldoon R.E. Ranney Metabolism of aspartame in monkeys J. Nutr. 103 1973 1454 1459
94. S. Puthrasnigam W.M. Heybroek A. Johnston V. Maskrey C.G. Swift P. Turner S.M.L. Abrams S.H.D. Jackson Aspartame pharmacokinetics: The effect of ageing Age Ageing 25 1996 217 220
95. R.E. Ranney J.A. Oppermann A review of metabolism of the aspartyl moiety of aspartame in experimental animals and man J. Environ. Pathol. Toxicol. 2 1979 979 985
96. R.E. Ranney J.A. Oppermann E. Muldoon F.G. McMahon Comparative metabolism of aspartame in experimental animals and humans J. Toxicol. Environ. Health. 2 1976 441 451
97. Stegink, L. D.1984. Aspartame metabolism in humans: Acute dosing studies. In Aspartame: Physiology and Biochemistry.L. D. Stegink and L. J. Filer, Jr., Eds., pp. 509–553. Marcel Dekker, New York.
98. L.D. Stegink The aspartame story: A model for the clinical testing of a food additive Am. J. Clin. Nutr. 46 1987 204 215
99. Stegink, L. D., and Filer, L. J. Jr.1996a. Effects of aspartame ingestion on plasma aspartate, phenylalanine, and methanol concentrations in normal adults. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 67–86. CRC Press, Boca Raton, FL.
100. Stegink, L. D., and Filer, L. J. Jr.1996b. Effects of aspartame ingestion on plasma aspartate, phenylalanine, and methanol concentrations in potentially sensitive populations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 87–113. CRC Press, Boca Raton, FL.
101. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers J. Nutr. 107 1977 1837 1845
102. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose J. Nutr. 109 1979 2173 2181
103. L.D. Stegink L.J. Filer Jr. G.L. Baker J.E. McDonnell Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects J. Nutr. 109 1979 708 717
104. L.D. Stegink L.J. Filer Jr. G.L. Baker J.E. McDonnell Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults J. Nutr. 110 1980 2216 2224
105. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame J. Toxicol. Environ. Health 7 1981 291 305
106. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame and sucrose loading in glutamate-susceptible subjects Am. J. Clin. Nutr. 34 1981 1899 1905
107. L.D. Stegink M.C. Brummel K. McMartin G. Martin-Amat L.J. Filer Jr. G.L. Baker T.R. Tephly Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame J. Toxicol. Environ. Health 7 1981 281 290
108. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame plus monosodium L -glutamate ingestion on plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal Am. J. Clin. Nutr. 36 1982 1145 1152
109. L.D. Stegink M.C. Brummel L.J. Filer Jr. G.L. Baker Blood methanol concentrations in one-year-old infants administered graded doses of aspartame J. Nutr. 113 1983 1600 1606
110. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma amino acid concentrations in normal adults fed meals with added monosodium L -glutamate and aspartame J. Nutr. 113 1983 1851 1860
111. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma amino acid concentrations in normal adults ingesting aspartame and monosodium L -glutamate as part of a soup/beverage meal Metabolism 36 1987 1073 1079
112. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Ziegler Plasma amino acid concentrations in normal adults administered aspartame in capsules or solution: Lack of bioequivalence Metabolism 36 1987 507 512
113. L.D. Stegink L.C. Wolf-Novak L.J. Filer Jr. E.F. Bell E.E. Ziegler W.L. Krause M.C. Brummel Aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults and adults heterozygous for phenylketonuria J. Nutr. 117 1987 1989 1995
114. L.D. Stegink L.J. Filer Jr. G.L. Baker Repeated ingestion of aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults Metabolism. 37 1988 246 251
115. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Ziegler T.R. Tephly Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults Metabolism 38 1989 357 363
116. L.D. Stegink L.J. Filer Jr. G.L. Baker E.F. Bell E.E. Ziegler M.C. Brummel W.L. Krause Repeated ingestion of aspartame-sweetened beverage: Effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria Metabolism 38 1989 78 84
117. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Ziegler T.R. Tephly W.L. Krause Repeated ingestion of aspartame-sweetened beverages: Further observations in individuals heterozygous for phenylketonuria Metabolism 39 1990 1076 1081
118. L.D. Stegink L.J. Filer Jr. M.C. Brummel G.L. Baker W.L. Krause E.F. Bell E.E. Ziegler Plasma amino acid concentrations and amino acid ratios in normal adults and adults heterozygous for phenylketonuria ingesting a hamburger and milk shake meal Am. J. Clin. Nutr. 53 1991 670 675
119. L.D. Stegink S.D. Lindgren M.C. Brummel P.J. Stumbo M.L. Wolraich Erythrocyte L -aspartyl- L -phenylalanine hydroxylase activity and plasma phenylalanine and aspartate concentrations in children consuming diets high in aspartame Am. J. Clin. Nutr. 62 1995 1206 1211
120. S.B. Stern S.J. Bleicher A. Flores G. Gombos D. Recitas J. Shu Administration of aspartame in non-insulin-dependent diabetics J. Toxicol. Environ. Health 2 1976 429 439
121. T.R. Tephly The toxicity of methanol Life Sci. 48 1991 1031 1041
122. Tephly, T. R., and McMartin, K. E.1984. Methanol metabolism and toxicity. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 111–140. Marcel Dekker, New York.
123. V.A. Tutelyan M.M. Gapparov O.A. Virovets L.V. Kravchenko A.V. Vasilyev A.I. Sokolov L.S. Konovalova L.G. Vasilevskaya G.K. Shlygin I.B. Tarasova T.A. Vorobeychik Y.E. Kuzmina New data on the metabolism and physiological mechanism of aspartame Vopr. Pitan. 1 1989 20 25
124. V.A. Tutelyan L.V. Kravchenko E.E. Kuzmina The effect of aspartame on the activity of rat liver xenobiotic-metabolizing enzymes Drug Metab. Dispos. 18 1990 223 225
125. L.C. Wolf-Novak L.D. Stegink M.C. Brummel T.J. Persoon L.J. Filer Jr. E.F. Bell E.E. Ziegler W.L. Krause Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: Effect on plasma concentrations of amino acids, glucose and insulin Metabolism 39 1990 391 396
126. M.L. Wolraich S.D. Lindgren P.J. Stumbo L.D. Stegink M.I. Appelbaum M.C. Kiritsy Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children N. Engl. J. Med. 330 1994 301 307
127. R. Abraham J. Swart L. Golberg F. Coulston Electron microscopic observations of hypothalami in neonatal rhesus monkeys ( Macaca mulatta ) after administration of monosodium- L -glutamate Exp. Mol. Pathol. 23 1975 203 213
128. R.L. Blaylock Excitotoxins: The Taste That Kills 1993 Health Press Santa Fe
129. T.T. Daabees M.W. Finkelstein L.D. Stegink A.E. Applebaum Correlation of glutamate plus aspartate dose, plasma amino acid concentration and neuronal necrosis in infant mice Food Chem. Toxicol. 23 1985 887 893
130. L.J. Filer Jr. G.L. Baker L.D. Stegink Effect of aspartame loading on plasma and erythrocyte free amino acid concentrations in one-year-old infants J. Nutr. 113 1983 1591 1599
131. M.W. Finkelstein T.T. Daabees L.D. Stegink A.E. Applebaum Correlation of aspartate dose, plasma dicarboxylic amino acid concentration and neuronal necrosis in infant mice Toxicology 29 1983 109 119
132. N. Lemkey-Johnston W.A. Reynolds Nature and extent of brain lesions in mice related to ingestion of monosodium glutamate J. Neuropathol. Exp. Neurol. 33 1974 74 97
133. A.S. Leon D.B. Hunninghake C. Bell D.K. Rassin T.R. Tephly Safety of long-term large doses of aspartame Arch. Intern. Med. 149 1989 2318 2324
134. B. Meldrum Amino acids as dietary excitotoxins: A contribution to understanding neurodegenerative disorders Brain Res. Rev. 18 1993 293 314
135. A.J. Newman R. Heywood A.K. Palmer D.H. Barry F.P. Edwards A.N. Worden The administration of monosodium L -glutamate to neonatal and pregnant rhesus monkeys Toxicology 1 1973 197 204
136. A. Okaniwa M. Hori M. Masuda M. Takeshita N. Hayashi I. Wada Histopathological study on effects of potassium aspartate on the hypothalamus of rats J. Toxicol. Sci. 4 1979 31 45
137. J.W. Olney Brain lesions, obesity, and other disturbances in mice treated with monosodium glutamate Science 164 1969 719 721
138. J.W. Olney Brain damage and oral intake of certain amino acids Adv. Exp. Biol. Med. 69 1976 497 506
139. J.W. Olney The toxic effects of glutamate and related compounds in the retina and the brain Retina 2 1982 341 359
140. J.W. Olney L.G. Sharpe Brain lesions in an infant rhesus monkey treated with monosodium glutamate Science 166 1969 386 388
141. J.W. Olney L.G. Sharpe R.D. Feigin Glutamate-induced brain damage in infant primates J. Neuropathol. Exp. Neurol. 31 1972 464 488
142. L. Reif-Lehrer Possible significance of adverse reactions to glutamate in humans Fed. Proc. 35 1976 2205 2212
143. W.A. Reynolds V. Bulter N. Lemkey-Johnston Hypothalamic morphology following ingestion of aspartame or MSG in the neonatal rodent and primate: A preliminary report J. Toxicol. Environ. Health 2 1976 471 480
144. Reynolds, W. A., Lemkey-Johnston, N., and Stegink, L. D.1979. Morphology of the fetal monkey hypothalamus after in utero exposure to monosodium glutamate. In Glutamic Acid: Advances in Biochemistry and PhysiologyL. J. Filer, Jr., S. Garattini, M. R. Kare, W. A. Reynolds, and R. J. Wurtman, Eds., pp. 217–229. Raven Press, New York.
145. W.A. Reynolds L.D. Stegink L.J. Filer Jr. E. Renn Aspartame administration to the infant monkey: Hypothalamic morphology and plasma amino acid levels Anat. Rec. 198 1980 73 84
146. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame and aspartate loading upon plasma and erythrocyte free amino acid levels in normal adult volunteers J. Nutr. 107 1977 1837 1845
147. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma, erythrocyte and human milk levels of free amino acids in lactating women administered aspartame or lactose J. Nutr. 109 1979 2173 2181
148. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma and erythrocyte concentrations of free amino acids in adult humans administered abuse doses of aspartame J. Toxicol. Environ. Health 7 1981 291 305
149. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame and sucrose loading in glutamate-susceptible subjects Am. J. Clin. Nutr. 34 1981 1899 1905
150. L.D. Stegink L.J. Filer Jr. G.L. Baker Effect of aspartame plus monosodium L -glutamate ingestion on plasma and erythrocyte amino acid levels in normal adult subjects fed a high protein meal Am. J. Clin. Nutr. 36 1982 1145 1152
151. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma amino acid concentrations in normal adults fed meals with added monosodium L -glutamate and aspartame J. Nutr. 113 1983 1851 1860
152. L.D. Stegink L.J. Filer Jr. G.L. Baker Plasma amino acid concentrations in normal adults ingesting aspartame and monosodium L -glutamate as part of a soup/beverage meal Metabolism. 36 1987 1073 1079
153. C.-P. Wen K.C. Hayes S.N. Gershoff Effects of dietary supplementation of monosodium glutamate on infant monkeys, weanling rats, and suckling mice Am. J. Clin. Nutr. 26 1973 803 813
154. B. Arvin A.G. Chapman B.S. Meldrum Extracellular levels of monoamines in striatum of baboon and rat following oral phenylalanine Soc. Neurosci. Abstr. 18 1992 24
155. T.S. Burns W.W. Stargel C. Tschanz F.N. Kotsonis A. Hurwitz Aspartame and sucrose produce a similar increase in the plasma phenylalanine to large neutral amino acid ratio in healthy-subjects Pharmacology 43 1991 210 219
156. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
157. B. Caballero B.E. Mahon F.J. Rohr H.L. Levy R.J. Wurtman Plasma amino acid levels after single-dose aspartame consumption in phenylketonuria, mild hyperphenylalaninemia, and heterozygous state for phenylketonuria J. Pediatr. 109 1986 668 671
158. R.A. Coulombe Jr. R.P. Sharma Neurobiochemical alterations induced by the artificial sweetener aspartame (NutraSweet) Toxicol. Appl. Pharmacol. 83 1986 79 85
159. J.W. Dailey S.M. Lasley P.K. Mishra A.F. Bettendorf R.L. Burger P.C. Jobe Aspartame fails to facilitate pentylenetetrazol-induced convulsions in CD-1 mice Toxicol. Appl. Pharmacol. 98 1989 475 486
160. J.W. Dailey S.M. Lasley R.L. Burger A.F. Bettendorf P.K. Mishra P.C. Jobe Amino acids, monoamines and audiogenic-seizures in genetically epilepsy-prone rats: Effects of aspartame Epilepsy Res. 8 1991 122 133
161. L. Diomede M. Romano G. Guiso S. Caccia S. Nava M. Salmona Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame Food Chem. Toxicol. 29 1991 101 106
162. J.D. Fernstrom Oral aspartame and plasma phenylalanine: Pharmacokinetic difference between rodents and man, and relevance to CNS effects of phenylalanine J. Neural Transm. 75 1989 159 164
163. J.D. Fernstrom R.J. Wurtman Brain serotonin content: Physiological regulation by plasma neutral amino acids Science 178 1972 414 416
164. J.D. Fernstrom M.H. Fernstrom M.A. Gillis Acute effects of aspartame on large neutral amino acids and monoamines in rat brain Life Sci. 32 1983 1651 1658
165. J.D. Fernstrom M.H. Fernstrom P.E. Grubb Effects of aspartame ingestion on the carbohydrate-induced rise in tryptophan hydroxylation rate in rat brain Am. J. Clin. Nutr. 44 1986 195 205
166. J.D. Fernstrom M.H. Fernstrom M.S. Massoudi In vivo tyrosine hydroxylation in rat retina: Effect of aspartame ingestion in rats pretreated with p -chlorophenylalanine Am. J. Clin. Nutr. 53 1991 923 929
167. S.B. Fountain S.K. Hennes T.J. Teyler Aspartame exposure and in vitro hippocampal slice excitability and plasticity Fundam. Appl. Toxicol. 11 1988 221 228
168. G. Freeman T. Sobotka D. Hattan Acute effects of aspartame on concentrations of brain amines and their metabolites in selected brain regions of Fischer-344 and Sprague–Dawley rats Drug Chem. Toxicol. 13 1990 113 133
169. Garattini, S., Caccia, S., Romano, M., Diomede, L., Guiso, G., Vezzani, A., and Salmona, M.1988. Studies on the susceptibility to convulsions in animals receiving abuse doses of aspartame. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 131–143. Birkhauser, Boston.
170. A.L. Goerss G.C. Wagner W.L. Hill Acute effects of aspartame on aggression and neurochemistry of rats Life Sci. 67 2000 1325 1329
171. N.Y. Helali H. El-Kashef H. Salem N. Gamiel M.M.A. Elmazar The effect of aspartame on seizure susceptibility and the anticonvulsant action of ethosuximide, valproate and phenytoin in mice Saudi Pharm. J. 4 1996 149 156
172. J.J. Hjelle R.E. Dudley M.P. Marietta P.G. Sanders B.C. Dickie J. Brisson F.N. Kotsonis Plasma concentrations and pharmacokinetics of phenylalanine in rats and mice administered aspartame Pharmacology 44 1992 48 60
173. M. Ikeda M. Levitt S. Udenfriend Phenylalanine as substrate and inhibitor of tyrosine hydroxylase Arch. Biochem. Biophys. 120 1967 420 427
174. R.A. Koeppe B.L. Shulkin K.C. Rosenspire L.A. Shaw A.L. Betz T. Mangner J.C. Price B.A. Agranoff Effect of aspartame-derived phenylalanine on neutral amino acid uptake in human brain: A positron emission tomography study J. Neurochem. 56 1991 1526 1535
175. A. Lajtha M.A. Reilly D.S. Dunlop Aspartame consumption: Lack of effects on neural function J. Nutr. Biochem. 5 1994 266 283
176. T.J. Maher R.J. Wurtman Possible neurologic effects of aspartame, a widely used food additive Environ. Health Perspect. 75 1987 53 57
177. Pan R. Martin-Du C. Mauron B. Glaeser R.J. Wurtman Effect of various oral glucose doses on plasma neutral amino acid levels Metabolism 31 1982 937 943
178. S.E. Møller Effect of aspartame and protein, administered in phenylalanine-equivalent doses, on plasma neutral amino acids, aspartate, insulin and glucose in man Pharmacol. Toxicol. 68 1991 408 412
179. 3H]glutamate binding sites in rat brain synaptic membranes Brain Res. 520 1990 351 353
180. C. Perego M.G. DeSimoni F. Fodritto L. Raimondi L. Diomede M. Salmona S. Algeri S. Garattini Aspartame and the rat brain monoaminergic system Toxicol. Lett. 44 1988 331 339
181. M.A. Reilly A. Lajtha Aspartame does not affect aminergic and glutamatergic receptor kinetics in rat brain Ann. N.Y. Acad. Sci. 757 1995 311 313
182. M.A. Reilly A. Lajtha Glutamatergic receptor kinetics are not altered by perinatal exposure to aspartame Neurochem. Int. 26 1995 217 222
183. M.A. Reilly E.A. Debler A. Lajtha Perinatal exposure to aspartame does not alter aminergic neurotransmitter systems in weanling rat brain Res. Commun. Psychol. Psychiatry Behav. 15 1990 141 159
184. M.A. Reilly E.A. Debler A. Fleischer A. Lajtha Chronic aspartame ingestion does not alter cerebral levels of aminergic neurotransmitters and related amino acids in the rat brain Res. Commun. Psychol. Psychiatry Behav. 14 1989 287 303
185. M.A. Reilly E.A. Debler A. Fleischer A. Lajtha Lack of effect of chronic aspartame ingestion on aminergic receptors in rat brain Biochem. Pharmacol. 38 1989 4339 4341
186. M. Romano F. Casacci F. De Marchi T. Pacei A. Esteve G. Lomuscio T. Mennini M. Salmona Effects of aspartame and carbohydrate administration on human and rat plasma large neutral amino acid levels and rat brain amino acid and monoamine levels J. Nutr. 119 1989 75 81
187. M. Romano L. Diomede G. Guiso S. Caccia C. Perego M. Salmona Plasma and brain kinetics of large neutral amino acids and of striatum monoamines in rats given aspartame Food Chem. Toxicol. 28 1990 317 321
188. R.P. Sharma R.A. Coulombe Jr. Effects of repeated doses of aspartame on serotonin and its metabolite in various regions of the mouse brain Food Chem. Toxicol. 25 1987 565 568
189. 45Ca influx and LDH leakage from nerve cells in culture NeuroReport 6 1995 318 320
190. Stegink, L. D., and Filer, L. J. Jr.1996a. Effects of aspartame ingestion on plasma aspartate, phenylalanine, and methanol concentrations in normal adults. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 67–86. CRC Press, Boca Raton, FL.
191. Stegink, L. D., and Filer, L. J. Jr.1996b. Effects of aspartame ingestion on plasma aspartate, phenylalanine, and methanol concentrations in potentially sensitive populations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 87–113. CRC Press, Boca Raton, FL.
192. L.D. Stegink M.C. Brummel T.J. Persoon L.J. Filer Jr. E.F. Bell E.E. Zeigler Effect of sucrose on the metabolic disposition of aspartame Am. J. Clin. Nutr. 52 1990 335 341
193. L.D. Stegink L.C. Wolf-Novak L.J. Filer Jr. E.F. Bell E.E. Zeigler W.L. Krause M.C. Brummel Aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults and adults heterozygous for phenylketonuria J. Nutr. 117 1987 1989 1995
194. R.G. Walton Seizure and mania after high intake of aspartame Psychosomatics 27 1986 218, 220
195. L.C. Wolf-Novak L.D. Stegink M.C. Brummel T.J. Persoon L.J. Filer Jr. E.F. Bell E.E. Ziegler W.L. Krause Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: Effect on plasma concentrations of amino acids, glucose, and insulin Metabolism 39 1990 391 396
196. R.J. Wurtman Neurochemical changes following high-dose aspartame with dietary carbohydrates N. Engl. J. Med. 309 1983 429 430
197. R.J. Wurtman Aspartame: Possible effect on seizure susceptibility Lancet 2 1985 1060
198. R.J. Wurtman T.J. Maher Effects of oral aspartame on plasma phenylalanine in humans and experimental rodents J. Neural Transm. 70 1987 169 173
199. H. Yokogoshi R.J. Wurtman Acute effects of oral or parenteral aspartame on catecholamine metabolism in various regions of rat brain J. Nutr. 116 1986 356 364
200. H. Yokogoshi C.H. Roberts B. Caballero R.J. Wurtman Effects of aspartame and glucose administration on brain and plasma levels of large neutral amino acids and brain 5-hydroxyindoles Am. J. Clin. Nutr. 40 1984 1 7
201. A.R. Alha J. Raehallio A.L. Muckula Detection of methanol poisoning with special consideration of the estimation of formic acid in solid viscera, blood and urine: Investigation of 11 fatal cases Ann. Med. Exp. Fenn. 36 1958 444 451
202. A. Bar C. Biermann Intake of intense sweeteners in Germany Z. Ernahrungswiss. 31 1992 25 39
203. Bergsten, C. 1993, Intake of Acesulfame-K, Aspartame, Cyclamate and Saccharin in Norway , SNT Report 3, Norwegian Food Control Authority, Oslo, Norway.
204. F. Bindler E. Voges P. Laugel The problem of methanol concentration admissible in distilled fruit spirits Food Addit. Contam. 5 1988 343 351
205. K.A. Black J.T. Eells P.E. Noker C.A. Hawley T.R. Tephly Role of hepatic tetrahydrofolate in the species difference in methanol toxicity Proc. Natl. Acad. Sci. USA 82 1985 3854 3858
206. H.H. Butchko F.N. Kotsonis Aspartame: Review of recent research Comments Toxicol. 3 1989 253 278
207. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
208. Butchko, H. H., and Kotsonis, F. N.1994. Postmarketing surveillance in the food industry: the aspartame case study. In Nutritional ToxicologyF. N. Kotsonis, M. Mackey, and J. Hjelle, Eds., pp. 235–250. Raven Press, New York.
209. Butchko, H. H., and Kotsonis, F. N.1996. Acceptable daily intake and estimation of consumption. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 43–53. CRC Press, Boca Raton, FL.
210. H.H. Butchko W.W. Stargel Aspartame: Scientific evaluation in the postmarketing period Regul. Toxicol. Pharmacol. 34 2001 221 233
211. H.H. Butchko C. Tschanz F.N. Kotsonis Postmarketing surveillance of food additives Regul. Toxicol. Pharmacol. 20 1994 105 118
212. M. Chambolle de Borely A. Collerie C. Renault J. Volatier Intake of Intense Sweeteners in France (1989–1992) 1994 CREDOC, Departement Prospective de la Consommation Paris
213. J.T. Eells M.M. Salzman M.F. Lewandowski T.G. Murray Formate-induced alterations in retinal function in methanol-intoxicated rats Toxicol. Appl. Pharmacol. 140 1996 58 69
214. Fed. Regist. 53 1988 41325 41329
215. Fed. Regist. 59 1994 5317 5320
216. Fed. Regist. 61 1996 26786 26788
217. I. Garnier-Sagne J.C. Leblanc P. Verger Calculation of the intake of three intense sweeteners in young insulin-dependent diabetics Food Chem. Toxicol. 39 2001 745 749
218. O. Grüner N. Bilzer J. Liebmann Zur methanolbildung in vitro und in vivo Blutalkohol. 31 1994 228 232
219. Proposal on Aspartame 1979 Health Protection Branch Ottawa
220. Z.I. Hertelendy C.I. Mendenhall S.D. Rouster L. Marshall R. Weesner Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease Am. J. Gastroenterol. 88 1993 737 743
221. J.P. Heybach C. Ross Aspartame consumption in a representative sample of Canadians J. Can. Diet. Assoc. 50 1989 166 170
222. A.L. Hinson W.M. Nicol Monitoring sweetener consumption in Great Britain Food Addit. Contam. 9 1992 669 680
223. Hulshof, K. F. A. M, and, Bouman, M. 1995, Use of Various Types of Sweeteners in Different Population Groups , 1992 Dutch National Food Consumption Survey, TNO Nutrition and Food Research Institute, Netherlands.
224. WHO Food Additive Series No. 15 1980 18 86
225. J.G. Kirchner J.M. Miller Volatile water-soluble and oil constituents of Valencia orange juice Agric. Food Chem. 5 1957 282 291
226. J.G. Kirchner J.M. Miller R.G. Rice G.J. Keller M.M. Fox Volatile water-soluble constituents of grapefruit juice Agric Food Chem. 1 1953 510 512
227. Kotsonis, F. N., and Hjelle, J. J.1996. The safety assessment of aspartame: Scientific and regulatory considerations. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 23–41. CRC Press, Boca Raton, FL.
228. C. Leclercq D. Berardi M.R. Sorbillo J. Lambe Intake of saccharin, aspartame, acesulfame K and cyclamate in Italian teenagers: Present levels and projections Food Addit. Contam. 16 1999 99 109
229. A.S. Leon D.B. Hunninghake C. Bell D.K. Rassin T.R. Tephly Safety of long-term large doses of aspartame Arch. Intern. Med. 149 1989 2318 2324
230. A.B. Makar T.R. Tephly Methanol poisoning in the folate-deficient rat Nature 261 1976 715 716
231. G. Martin-Amat T.R. Tephly K.E. McMartin A.B. Makar M.S. Hayreh S.S. Hayreh G. Baumbach P. Cancilla Methyl alcohol poisoning. II. Development of a model for ocular toxicity in methyl alcohol poisoning using the rhesus monkey Arch. Ophthalmol. 95 1977 1847 1850
232. G. Martin-Amat K.E. McMartin S.S. Hayreh M.S. Hayreh T.R. Tephly Methanol poisoning: Ocular toxicity produced by formate Toxicol. Appl. Pharmacol. 45 1978 201 208
233. K.E. McMartin A.B. Makar G. Martin-Amat M. Palese T.R. Tephly Methanol poisoning. I. The role of formic acid in the development of metabolic acidosis in the monkey and the reversal by 4-methylpyrazole Biochem. Med. 13 1975 319 333
234. K.E. McMartin G. Martin-Amat A.B. Makar T.R. Tephly Methanol poisoning. V. Role of formate metabolism in the monkey J. Pharmacol. Exp. Ther. 201 1977 564 572
235. K.E. McMartin G. Martin-Amat P.E. Noker T.R. Tephly Lack of a role for formaldehyde in methanol poisoning in the monkey Biochem. Pharmacol. 28 1979 645 649
236. Ministry of Agriculture Fisheries and Food (MAFF), 1990, Intakes of Intense and Bulk Sweeteners in the UK 1987–1988 , Food Surveillance Paper No. 29, London, UK.
237. Survey of the Intake of Sweeteners by Diabetics 1995 Food Surveillance Information Sheet. Food Safety Directorate London
238. T.G. Murray T.C. Burton C. Rajani M.F. Lewandowski J.M. Burke J.T. Eells Methanol poisoning: A rodent model with structural and functional evidence for retinal involvement Arch. Ophthalmol. 109 1991 1012 1016
239. National Food Authority Australia, 1995, Survey of Intense Sweetener Consumption in Australia: Final Report , Canberra, Australia.
240. P. Nicholls The effects of formate on cytochrome aa3 and on electron transport in the intact respiratory chain Biochim. Biophys. Acta 430 1976 13 29
241. P.E. Noker J.T. Eells T.R. Tephly Methanol toxicity: Treatment with folic acid and 5-formyl-tetrahydrofolic acid Alcohol. Clin. Exp. Res. 4 1980 378 383
242. Reports of the Scientific Committee for Food, sixteenth series 1985 Commission of the European Communities Luxembourg
243. O.M. Sejersted D. Jacobsen S. Ovrebo H. Jansen Formate concentrations in plasma from patients poisoned with methanol Acta Med. Scand. 213 1983 105 110
244. M.T. Seme P. Summerfelt J. Neitz J.T. Eells M.M. Henry Differential recovery of retinal function after mitochondrial inhibition by methanol intoxication Invest. Ophthalmol. Vis. Sci. 42 2001 834 841
245. B.A. Shaywitz C.M. Sullivan G.M. Anderson S.M. Gillespie B. Sullivan S.E. Shaywitz Aspartame, behavior, and cognitive function in children with attention deficit disorder Pediatrics 93 1994 70 75
246. H. Sommer The physiological fate of methylalcohol released from pectin Industrielle Obst. Gemüseverwertung. 47 1962 172 173
247. L.D. Stegink M.C. Brummel K. McMartin G. Martin-Amat L.J. Filer Jr. G.L. Baker T.R. Tephly Blood methanol concentrations in normal adult subjects administered abuse doses of aspartame J. Toxicol. Environ. Health 7 1981 281 290
248. L.D. Stegink M.C. Brummel L.J. Filer Jr. G.L. Baker Blood methanol concentrations in one-year-old infants administered graded doses of aspartame J. Nutr. 113 1983 1600 1606
249. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Zeigler T.R. Tephly Effect of repeated ingestion of aspartame-sweetened beverage on plasma amino acid, blood methanol, and blood formate concentrations in normal adults Metabolism 38 1989 357 363
250. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Zeigler T.R. Tephly W.L. Krause Repeated ingestion of aspartame-sweetened beverages: Further observations in individuals heterozygous for phenylketonuria Metabolism 39 1990 1076 1081
251. J. Taucher A. Lagg A. Hansel W. Vogel W. Lindinger Methanol in human breath Alcohol. Clin. Exp. Res. 19 1995 1147 1150
252. T.R. Tephly The toxicity of methanol Life Sci. 48 1991 1031 1041
253. T.R. Tephly Comments on the purported generation of formaldehyde and adduct formation from the sweetener aspartame Life Sci. 65 1999 157 160
254. C. Trocho R. Pardo I. Rafecas J. Virgili X. Remesar J.A. Fernandez-Lopez M. Alemany Formaldehyde derived from dietary aspartame binds to tissue components in vivo Life Sci. 63 1998 337 349
255. M.C.F. Toledo S.H. Ioshi Potential intake of intense sweeteners in Brazil Food Addit. Contam. 12 1995 799 808
256. L. Uotila M. Koivusalo Formaldehyde dehydrogenase from human liver: Purification, properties and evidence for the formation of glutathionine thiol esters by the enzyme J. Biol. Chem. 249 1974 7653 7663
257. S.M. Virtanen L. Rasanen A. Paganus P. Varo H.K. Akerblom Intake of sugars and artificial sweeteners by adolescent diabetics Nutr. Rep. Int. 38 1988 1211 1218
258. World Health Organization (WHO), 1997, Environmental Health Criteria 196: Methanol , WHO, Geneva.
259. K. Wucherpfennig H. Dietrich J. Bechtel Vorhandener, gesamter und potentieller methylalkoholgehalt von fruchtsaften Flussiges Obst. 8 1983 348 354
260. Agencia, Saude, 1999, Forum of scientific discussion: Aspartame, Sao Paulo, Brazil, October 29, 1999, http://anvs1.saude.gov.br/Alimento/aspartame.html .
261. M.K. Bradstock M.K. Serdula J.S. Marks R.J. Barnard N.T. Crane P.L. Remington F.L. Trowbridge Evaluation of reactions to food additives: The aspartame experience Am. J. Clin. Nutr. 43 1986 464 469
262. H.H. Butchko F.N. Kotsonis Aspartame: Review of recent research Comments Toxicol. 3 1989 253 278
263. Butchko, H. H., and Kotsonis, F. N.1994. Postmarketing surveillance in the food industry: the aspartame case study. In Nutritional ToxicologyF. N. Kotsonis, M. Mackey, and J. Hjelle, Eds., pp. 235–250. Raven Press, New York.
264. Butchko, H. H., and Kotsonis, F. N.1996. Acceptable daily intake and estimation of consumption. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 43–53. CRC Press, Boca Raton, FL.
265. H.H. Butchko C. Tschanz F.N. Kotsonis Postmarketing surveillance of food additives Regul. Toxicol. Pharmacol. 20 1994 105 118
266. Butchko, H. H., Tschanz, C., and Kotsonis, F. N.1996. Postmarketing surveillance of anecdotal medical complaints. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 183–193. CRC Press, Boca Raton, FL.
267. Butchko, H. H., Stargel, W. W., Comer, C. P., Mayhew, D. A., and Andress, S. E.2001. Aspartame. In Alternative Sweeteners, 3rd edition. L. O. Nabors, Ed., pp. 41–61. Marcel Dekker, New York.
268. H.H. Butchko W.W. Stargel Aspartame: Scientific evaluation in the postmarketing period Regul. Toxicol. Pharmacol. 34 2001 221 233
269. Butchko, H. H., and Stargel, W. W.2002. Postmarketing surveillance in the food industry: the aspartame case study. In Nutritional ToxicologyF. N. Kotsonis and M. Mackey, Eds., second ed., pp. 287–315. Taylor & Francis, London/New York.
270. J. Caseley W. Dixon Aspartame: In perspective Nutr. Food Sci. 31 2001 23 26
271. Evaluation of Consumer Complaints Related to Aspartame Use 1984 CDC Atlanta
272. G.A. Faich Adverse-drug-reaction monitoring N. Engl. J. Med. 314 1986 1589 1592
273. Summary of Adverse Reactions Attributed to Aspartame 1995 FDA Washington
274. Food Standards Agency (FSA), 2000, Food Safety Information Bulletin No. 117, www.foodstandards.gov.uk/maff/archive/food/bulletin/2000/no117/asparte.htm .
275. J. Henkel Sugar substitutes: Americans opt for sweetness and lite FDA Consumer 1999 12 16
276. Roberts, H. J.1988a. Neurological, psychiatric, and behavioral reactions to aspartame in 505 aspartame reactors. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 373–376. Birkhauser, Boston.
277. H.J. Roberts Reactions attributed to aspartame-containing products: 551 cases J. Appl. Nutr. 40 1988 85 94
278. H.J. Roberts Aspartame (NutraSweet): Is It Safe? 1990 Charles Press Philadelphia
279. A.R. Rolla Aspartame (NutraSweet): Is it safe? (book review) N. Engl. J. Med. 323 1990 1495 1496
280. S. Schiffman H.J. Roberts Adverse reactions to aspartame (letter) J. Appl. Nutr. 41 1989 40
281. Squillacote, D. 1999a, Aspartame (NutraSweet): No Danger. , The Multiple Sclerosis Foundation, www.msfocus.org/aspar.htm .
282. Squillacote, D. 1999b, Aspartame: Come in from the Ledge . The Multiple Sclerosis Foundation, www.msfacts.org/aspart2.htm .
283. L. Tollefson Monitoring adverse reactions to food additives in the U.S. Food and Drug Administration Regul. Toxicol. Pharmacol. 8 1988 438 446
284. Tollefson, L., Barnard, R. J., and Glinsmann, W. H.1988. Monitoring of adverse reactions to aspartame reported to the U.S. Food and Drug Administration. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 317–337. Birkhauser, Boston.
285. L. Tollefson R.J. Barnard An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame J. Am. Diet. Assoc. 92 1992 598 601
286. L. Tollefson Multiple chemical sensitivity: Controlled scientific studies as proof of causation Regul. Toxicol. Pharmacol. 18 1993 32 43
287. W.K. Amery More on aspartame and headache Headache 28 1988 624
288. H.J. Blumenthal D.A. Vance Chewing gum headaches Headache 37 1997 665 666
289. M.K. Bradstock M.K. Serdula J.S. Marks R.J. Barnard N.T. Crane P.L. Remington F.L. Trowbridge Evaluation of reactions to food additives: The aspartame experience Am. J. Clin. Nutr. 43 1986 464 469
290. T.S. Burns W.W. Stargel A. Hurwitz Bioavailability of phenylalanine and aspartate from aspartame (20 mg/kg) in capsules and solution Metabolism 39 1990 1200 1203
291. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
292. Evaluation of Consumer Complaints Related to Aspartame Use 1984 CDC Atlanta
293. L.J. Elsas Aspartame and headache (letter) N. Engl. J. Med. 318 1988 1201
294. M.A. Frasca J.C. Aldag The single-patient clinical trial Am. Fam. Phys. 37 1988 195 199
295. G.E. Gaull Response to Johns “Migraine provoked by aspartame” (letter) N. Engl. J. Med. 315 1986 456
296. D.R. Johns Migraine provoked by aspartame (letter) N. Engl. J. Med. 315 1986 456
297. S.M. Koehler A. Glaros The effect of aspartame on migraine headache Headache 28 1988 10 14
298. A.S. Leon D.B. Hunninghake C. Bell D.K. Rassin T.R. Tephly Safety of long-term large doses of aspartame Arch. Intern. Med. 149 1989 2318 2324
299. P.S. Levy D. Hedeker P. Sanders Aspartame and headache (letter) Neurology 45 1995 1631 1632
300. M.S. Linet W.F. Stewart D.D. Celentano D. Ziegler M. Sprecher An epidemiologic study of headache among adolescents and young adults JAMA 261 1989 2211 2216
301. R.B. Lipton L.C. Newman S. Solomon Aspartame and headache (letter) N. Engl. J. Med. 318 1988 1200
302. R.B. Lipton L.C. Newman J.S. Cohen S. Solomon Aspartame as a dietary trigger of headache Headache 29 1989 90 92
303. R.E. Ranney J.A. Oppermann E. Muldoon F.G. McMahon Comparative metabolism of aspartame in experimental animals and humans J. Toxicol. Environ. Health 2 1976 441 451
304. H.J. Roberts Aspartame and headache (letter) Neurology 45 1995 1631
305. S.S. Schiffman Aspartame and headache (letter) Headache 28 1988 370
306. S. Schiffman Aspartame and headache (letter) Neurology 45 1995 1632
307. S.S. Schiffman C.E. Buckley H.A. Sampson E.W. Massey J.N. Baraniuk J.V. Follett Z.S. Warwick Aspartame and susceptibility to headache N. Engl. J. Med. 317 1987 1181 1185
308. S.S. Schiffman C.E. Buckley H.A. Sampson E.W. Massey J.N. Baraniuk J.V. Follett Z.S. Warwick Aspartame and headache (letter) N. Engl. J. Med. 318 1988 1201 1202
309. L.D. Stegink The aspartame story: A model for the clinical testing of a food additive Am. J. Clin. Nutr. 46 1987 204 215
310. R.V. Steinmetzer R.S. Kunkel Aspartame and headache (letter) N. Engl. J. Med. 318 1988 1201
311. L. Tollefson Monitoring adverse reactions to food additives in the U.S. Food and Drug Administration Regul. Toxicol. Pharmacol. 8 1988 438 446
312. Tollefson, L., Barnard, R. J., and Glinsmann, W. H.1988. Monitoring of adverse reactions to aspartame reported to the U.S. Food and Drug Administration. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 317–337. Birkhauser, Boston.
313. C. Tschanz H.H. Butchko W.W. Stargel F.N. Kotsonis The Clinical Evaluation of A Food Additive: Assessment of Aspartame 1996 CRC Press Boca Raton
314. S.K. Van Den Eeden T.D. Koepsell W.T. Longstreth G. van Belle J.R. Daling B. McKnight Aspartame ingestion and headaches: A randomized crossover trial Neurology 44 1994 1787 1793
315. R.S. Watts Aspartame, headaches and beta blockers (letter) Headache 31 1991 181
316. Anderson, G. M., Novotny, E. J. Jr., and Shaywitz, B. A.1996. Evaluation of seizures. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 205–216. CRC Press, Boca Raton, FL.
317. A.F. Bettendorf J.W. Dailey S.M. Lasley P.C. Jobe Aspartame fails to facilitate bicuculline-induced seizures in DBA/2 mice Soc. Neurosci. Abstr. 15 1989 47
318. M.K. Bradstock M.K. Serdula J.S. Marks R.J. Barnard N.T. Crane P.L. Remington F.L. Trowbridge Evaluation of reactions to food additives: The aspartame experience Am. J. Clin. Nutr. 43 1986 464 469
319. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
320. H.H. Butchko W.W. Stargel Aspartame: Scientific evaluation in the postmarketing period Regul. Toxicol. Pharmacol. 34 2001 221 233
321. D.P. Cain F. Boon M. Bevan Failure of aspartame to affect seizure susceptibility in kindled rats Neuropharmacology 28 1989 433 435
322. P.R. Camfield C.S. Camfield J.M. Dooley K. Gordon S. Jollymore D.F. Weaver Aspartame exacerbates EEG spike-wave discharge in children with generalized absence epilepsy: A double-blind controlled study Neurology 42 1992 1000 1003
323. Evaluation of Consumer Complaints Related to Aspartame Use 1984 CDC Atlanta
324. P. Chin D.M. Woodbury Effects of aspartame (ASM) and its metabolites on seizure susceptibility in mice Pharmacologist 30 1988 A119
325. J.W. Dailey S.M. Lasley A.F. Bettendorf R. Burger P.C. Jobe Aspartame does not facilitate pentylenetetrazol-induced seizures in genetically epilepsy-prone rats Epilepsia 29 1988 651
326. J.W. Dailey S.M. Lasley P.K. Mishra A.F. Bettendorf R.L. Burger P.C. Jobe Aspartame fails to facilitate pentylenetetrazol-induced convulsions in CD-1 mice Toxicol. Appl. Pharmacol. 98 1989 475 486
327. J.W. Dailey S.M. Lasley R.L. Burger A.F. Bettendorf P.K. Mishra P.C. Jobe Amino acids, monoamines and audiogenic seizures in genetically epilepsy-prone rats: Effects of aspartame Epilepsy Res. 8 1991 122 133
328. L. Diomede M. Romano G. Guiso S. Caccia S. Nava M. Salmona Interspecies and interstrain studies on the increased susceptibility to metrazol-induced convulsions in animals given aspartame Food Chem. Toxicol. 29 1991 101 106
329. Elsas, L. J., and Trotter, J. F.1988. Changes in physiological concentrations of blood phenylalanine produce changes in sensitive parameters of human brain function. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 187–195. Birkhauser, Boston.
330. C.M. Epstein J.F. Trotter A. Averbook S. Freeman M.H. Kutner L.J. Elsas EEG mean frequencies are sensitive indices of phenylalanine effects on normal brain Electroencephalogr. Clin. Neurophysiol. 72 1989 133 139
331. Y. Eshel I. Sarova-Pinhas Aspartame and seizures (letter) Neurology 43 1993 2154 2155
332. Garattini, S., Caccia, S., Romano, M., Diomed, L., Guiso, G., Vezzani, A., and Salmona, M.1988. Studies on the susceptibility to convulsions in animals receiving abuse doses of aspartame. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 131–143. Birkhauser, Boston.
333. G. Guiso S. Caccia A. Vezzani M.A. Stasi M. Salmona M. Romano S. Garattini Effect of aspartame on seizures in various models of experimental epilepsy Toxicol. Appl. Pharmacol. 96 1988 485 493
334. G. Guiso L. Diomede M. Romano S. Caccia S. Sarati M. Salmona Effect of tyrosine on the potentiation by aspartame and phenylalanine of metrazol-induced convulsions in rats Food Chem. Toxicol. 29 1991 855 857
335. N.Y. Helali H. El-Kashef H. Salem N. Gamiel M.M.A. Elmazar The effect of aspartame on seizure susceptibility and the anticonvulsant action of ethosuximide, valproate and phenytoin in mice Saudi Pharm. J. 4 1996 149 156
336. P.C. Jobe J.W. Dailey Aspartame and seizures Amino Acids 4 1993 197 235
337. P.C. Jobe A.F. Bettendorf S.M. Lasley J.W. Dailey Multiple exposures to audiogenic stimuli in DBA/2 mice: Lack of effect of aspartame Epilepsia 30 1989 653
338. P.C. Jobe A.F. Bettendorf S.M. Lasley J.W. Dailey Audiogenic seizures in DBA/2 mice are not facilitated by aspartame Soc. Neurosci. Abstr. 15 1989 47
339. P.C. Jobe S.M. Lasley R.L. Burger A.F. Bettendorf P.K. Mishra J.W. Dailey Absence of an effect of aspartame on seizures induced by electroshock in epileptic and non-epileptic rats Amino Acids 3 1992 155 172
340. K.C. Kim S.H. Kim Studies on the effect of aspartame and lidocaine interaction in central nervous system in mice Fed. Proc. 46 1987 705
341. Kim, K. C., Tasch, M. D., and Kim, S. H., 1988. The effect of aspartame on 50% convulsion doses of lidocaine. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 127–130. Birkhauser, Boston.
342. B.S. Meldrum N. Nanji R.G. Cornell Lack of effect of aspartame or of L -phenylalanine on photically induced myoclonus in the baboon, Papio papio Epilepsy Res. 4 1989 1 7
343. Nevins, M. E., Arnolde, S. M., and Haigler, H. J.1987. Aspartame: Lack of effect on convulsant thresholds in mice. In Amino Acids in Health and Disease: New PerspectivesS. Kaufman, Ed., pp. 437–449. Liss, Inc. New York.
344. J.M.B. Pinto T.J. Maher Administration of aspartame potentiates pentylenetetrazole- and fluorothyl-induced seizures in mice Neuropharmacology 27 1988 51 55
345. Rao, K. S, McConnell, R. G, and, Waisman, H. A. 1972, SC-18862: 52 Week Oral Toxicity Study in the Infant Monkey , G. D. Searle and Co. research report submitted to FDA Record, Aspartame 75F-0355 (File E-32).
346. Reynolds, W. A., Bauman, A. F., Stegink, L. D., Filer, L. J. Jr., and Naidu, S.1984. Developmental assessment of infant macaques receiving dietary aspartame or phenylalanine. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 405–423. Marcel Dekker, New York.
347. H.J. Roberts Aspartame (NutraSweet)-associated epilepsy Clin. Res. 36 1988 349A
348. A.J. Rowan B.A. Shaywitz L. Tuchman J.A. French D. Luciano C.M. Sullivan Aspartame and seizure susceptibility: Results of a clinical study in reportedly sensitive individuals Epilepsia 36 1995 270 275
349. K. Schlesinger R.A. Schreiber B.J. Griek K.R. Henry Effects of experimentally induced phenylketonuria on seizure susceptibility in mice J. Comp. Physiol. Psychol. 67 1969 149 155
350. B.A. Shaywitz E.J. Novotny Jr. Reply to Camfield et al. “Aspartame and seizures” (letter) Neurology 43 1993 630
351. B.A. Shaywitz G.M. Anderson E.J. Novotny J.S. Ebersole C.M. Sullivan S.M. Gillespie Aspartame has no effect on seizures or epileptiform discharges in epileptic children Ann. Neurol. 35 1994 98 103
352. E.F. Sperber S.L. Moshe D.L. Dow-Edwards Prenatal exposure to aspartame and seizure susceptibility J. Epilepsy 8 1995 51 56
353. P.A. Spiers L. Sabaounjian A. Reiner D.K. Myers J. Wurtman D.L. Schomer Aspartame: Neuropsychologic and neurophysiologic evaluation of acute and chronic effects Am. J. Clin. Nutr. 68 1998 531 537
354. Suomi, S. J.1984. Effects of aspartame on the learning test performance of young stumptail macaques. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 425–445. Dekker, New York.
355. H.A. Tilson L. Thai D. Zhao T.J. Sobotka J.S. Hong Oral administration of aspartame is not proconvulsant in rats NeuroToxicology 10 1989 229 238
356. L. Tollefson Monitoring adverse reactions to food additives in the U. S. Food and Drug Administration Regul. Toxicol. Pharmacol. 8 1988 438 446
357. L. Tollefson Multiple chemical sensitivity: Controlled scientific studies as proof of causation Regul. Toxicol. Pharmacol. 18 1993 32 43
358. L. Tollefson R.J. Barnard An analysis of FDA passive surveillance reports of seizures associated with consumption of aspartame J. Am. Diet. Assoc. 92 1992 598 601
359. F. Trefz L. de Sonneville P. Matthis C. Benninger B. Lanz-Englert H. Bickel Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine) Hum. Genet. 93 1994 369 374
360. T.C. Truscott Effects of phenylalanine and 5-hydroxy-tryptophan on seizure severity in mice Pharmacol. Biochem. Behav. 3 1975 939 941
361. R.G. Walton Seizure and mania after high intake of aspartame Psychosomatics 27 1986 218, 220
362. R.J. Wurtman Aspartame: Possible effect on seizure susceptibility (letter) Lancet 2 1985 1060
363. J. Zhi G. Levy Aspartame and phenylalanine do not enhance theophylline-induced seizure in rats Res. Commun. Chem. Pathol. Pharmacol. 66 1989 171 174
364. R.G. Barr M.S. Pantel S.N. Young J.H. Wright L.A. Hendricks R. Gravel The response of crying newborns to sucrose: Is it a “sweetness” effect? Physiol. Behav. 66 1999 409 417
365. de Sonneville, L. M. J.1999. Amsterdam Neuropsychological Tasks: A computer-aided assessment program. In Cognitive Ergonomics, Clinical Assessment and Computer-Assisted Learning: Computers in PsychologyB. P. L. M. Den Brinker, P. J. Beek, A. N. Brand, S. J. Maarse, and L. J. M. Mulder, Eds., pp. 187–203. Swets & Zeitlinger, Lisse, The Netherlands.
366. R.E. Dodge D. Warner S. Sangal R.D. O'Donnell The effect of single and multiple doses of aspartame on higher cognitive performance in humans 61st Annual Scientific Meeting, Aerospace Medical Association 1990 A30
367. H.B. Ferguson C. Stoddart J.G. Simeon Double-blind challenge studies of behavioral and cognitive effects of sucrose-aspartame ingestion in normal children Nutr. Rev. 44 1986 144 150
368. A.L. Goerss G.C. Wagner W.L. Hill Acute effects of aspartame on aggression and neurochemistry of rats Life Sci. 67 2000 1325 1329
369. J.A. Goldman R.H. Lerman J.H. Contois J.N. Udall Jr. Behavioral effects of sucrose on preschool children J. Abnorm. Child Psychol. 14 1986 565 577
370. M.D. Holder R. Yirmiya Behavioral assessment of the toxicity of aspartame Pharmacol. Biochem. Behav. 32 1989 17 26
371. D.W. Hoover R. Milich Effects of sugar ingestion expectancies on mother–child interactions J. Abnorm. Child Psychol. 22 1994 501 515
372. S.C.J. Huijbregts L.M.J. de Sonneville R. Licht F.J. van Spronsen P.H. Verkerk J.A. Sergeant Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations Neuropsychologia 40 2002 7 15
373. M.J.P. Kruesi J.L. Rapoport E.M. Cummings C.J. Berg D.R. Ismond M. Flament M. Yarrow C. Zahn-Waxler Effects of sugar and aspartame on aggression and activity in children Am. J. Psychiatry 144 1987 1487 1490
374. C.J. LaBuda R.L. Hale Anxiety in mice following acute aspartame and ethanol exposure Alcohol 20 2000 69 74
375. K.A. Lapierre D.J. Greenblatt J.E. Goddard J.S. Harmatz R.I. Shader The neuropsychiatric effects of aspartame in normal volunteers J. Clin. Pharmacol. 30 1990 454 460
376. Lieberman, H. R., Caballero, B., Emde, G. G., and Bernstein, J. G.1988. The effects of aspartame on human mood, performance, and plasma amino acid levels. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 196–200. Birkhauser, Boston.
377. L.K. Mahan M. Chase C.T. Furukawa S. Sulzbacher G.G. Shapiro W.E. Pierson C.W. Bierman Sugar “allergy” and children's behavior Ann. Allergy 61 1988 453 458
378. R. Milich W.E. Pelham Effects of sugar ingestion on the classroom and playgroup behavior of attention deficit disordered boys J. Consult. Clin. Psychol. 54 1986 714 718
379. P.J. Mullenix M.S. Tassinari A. Schunior W.J. Kernan No change in spontaneous behavior of rats after acute oral doses of aspartame, phenylalanine, and tyrosine Fundam. Appl. Toxicol. 16 1991 495 505
380. E.E.A. Pivonka K.K. Grunewald Aspartame- or sugar-sweetened beverages: Effects on mood in young women J. Am. Diet. Assoc. 90 1990 250 254
381. L.A. Rosen M.E. Bender S. Sorrell S.R. Booth M.L. McGrath R.S. Drabman Effects of sugar (sucrose) on children's behavior J. Consult. Clin. Psychol. 56 1988 583 589
382. M. Ryan-Harshman L.A. Leiter G.H. Anderson Phenylalanine and aspartame fail to alter feeding behavior, mood and arousal in men Physiol. Behav. 39 1987 247 253
383. S. Saravis R. Schachar S. Zlotkin L.A. Leiter G.H. Anderson Aspartame: Effects on learning, behavior, and mood Pediatrics 86 1990 75 83
384. E. Schmidt A. Rupp P. Burgard J. Pietz J. Weglage L. De Sonneville Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine blood level J. Clin. Exp. Neuropsychol. 16 1994 681 688
385. Schomer, D. L., Spiers, P., and Sabounjian, L. A.1996. Evaluation of behavior, cognition, mood, and electroencephalograms in normal adults and potentially vulnerable populations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 217–233. CRC Press, Boca Raton, FL.
386. B.A. Shaywitz G.M. Anderson E.J. Novotny J.S. Ebersole C.M. Sullivan S.M. Gillespie Aspartame has no effect on seizures or epileptiform discharges in epileptic children Ann. Neurol. 35 1994 98 103
387. B.A. Shaywitz C.M. Sullivan G.M. Anderson S.M. Gillespie B. Sullivan S.E. Shaywitz Aspartame, behavior, and cognitive function in children with attention deficit disorder Pediatrics 93 1994 70 75
388. Spiers, P., Schomer, D., Sabounjian, L., Lieberman, H., Wurtman, R., Duguid, J., McCarten, R., and Lyden, M.1988. Aspartame and human behavior: congnitive and behavioral observations. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 169–178. Birkhauser, Boston.
389. P.A. Spiers L. Sabounjian A. Reiner D.K. Myers J. Wurtman D.L. Schomer Aspartame: Neuropsychologic and neurophysiologic evaluation of acute and chronic effects Am. J. Clin. Nutr. 68 1998 531 537
390. A.F. Stokes A. Belger M.T. Banich H. Taylor Effects of acute aspartame and acute alcohol ingestion upon the cognitive performance of pilots Aviat. Space Environ. Med. 62 1991 648 653
391. A.F. Stokes A. Belger M.T. Banich E. Bernadine Effects of alcohol and chronic aspartame ingestion upon performance in aviation relevant cognitive tasks Aviat. Space Environ. Med. 65 1994 7 15
392. Suomi, S. J.1984. Effects of aspartame on the learning test performance of young stumptail macaques. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 425–445. Marcel Dekker, New York.
393. H.A. Tilson J.S. Hong T.J. Sobotka High doses of aspartame have no effects on sensorimotor function or learning and memory in rats Neurotoxicol. Teratol. 13 1991 27 35
394. F. Trefz L. de Sonneville P. Matthis C. Benninger B. Lanz-Englert H. Bickel Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine) Hum. Genet. 93 1994 369 374
395. E.H. Wender M.V. Solanto Effects of sugar on aggressive and inattentive behavior in children with attention deficit disorder with hyperactivity and normal children Pediatrics 88 1991 960 966
396. M. Wolraich R. Milich P. Stumbo F. Schultz Effects of sucrose ingestion on the behavior of hyperactive boys J. Pediatr. 106 1985 675 682
397. M.L. Wolraich S.D. Lindgren P.J. Stumbo L.D. Stegink M.I. Appelbaum M.C. Kiritsy Effects of diets high in sucrose or aspartame on the behavior and cognitive performance of children N. Engl. J. Med. 330 1994 301 307
398. R.L. Aspinall R.N. Saunders W.F. Pautsch E.F. Nutting Effects on a variety of physiological parameters related to inflammation and metabolism J. Environ. Pathol. Toxicol. 3 1980 387 395
399. G.A. Burr B.P. Bernard Health Hazard Evaluation Report No. HETA-86-035-2224 Govt. Rep. Announce. Index 1992
400. Evaluation of Consumer Complaints Related to Aspartame Use 1984 CDC Atlanta
401. M.M. Garriga C. Berkebile D.D. Metcalfe A combined single-blind, double-blind, placebo-controlled study to determine the reproducibility of hypersensitivity reactions to aspartame J. Allergy Clin. Immunol. 87 1991 821 827
402. R.S. Geha Aspartame-induced lobular panniculitis (letter) J. Am. Acad. Dermatol. 26 1992 277 278
403. R. Geha C.E. Buckley P. Greenberger R. Patterson S. Polmar A. Saxon A. Rohr W. Yang M. Drouin Aspartame is no more likely than placebo to cause urticaria/angioedema: Results of a multicenter, randomized, double-blind, placebo-controlled, crossover study J. Allergy Clin. Immunol. 92 1993 513 520
404. A. Kulczycki Jr. Aspartame-induced urticaria Ann. Intern. Med. 104 1986 207 208
405. A. Kulczycki Jr. Aspartame-induced hives (letter) J. Allergy Clin. Immunol. 95 1995 639 640
406. D.P. McCauliffe K. Poitras Aspartame-induced lobular panniculitis J. Am. Acad. Dermatol. 25 1991 298 300
407. N.L. Novick Aspartame-induced granulomatous panniculitis Ann. Intern. Med. 102 1985 206 207
408. E.F. Szucs K.E. Barrett D.D. Metcalfe The effects of aspartame on mast cells and basophils Food Chem. Toxicol. 24 1986 171 174
409. B. Wedi S. Wagner T. Werfel M.P. Manns A. Kapp Prevalence of Helicobacter pylori -associated gastritis in chronic urticaria Int. Arch. Allergy Immunol. 116 1998 288 294
410. Aspartame: Information for Consumers 1997
411. J.F. Borzelleca G.K. Hogan A. Koestner Chronic toxicity/carcinogenicity study of FD&C Blue No. 2 in rats Food Chem. Toxicol. 23 1985 551 558
412. P. Boyle P. Maisonneuve R. Saracci C.S. Muir Is the increased incidence of primary malignant brain tumors in the elderly real? J. Natl. Cancer Inst. 82 1990 1594 1596
413. H. Butchko Reply to H. J. Roberts “Does aspartame cause human brain cancer” (letter) J. Adv. Med. 5 1992 257 259
414. J. Caseley W. Dixon Aspartame: In perspective Nutr. Food Sci. 31 2001 23 26
415. B.C. Challis S.J. Lomas H.S. Rzepa A kinetic model for the formation of gastric N-nitroso compounds Acta Cien. Compost. 19 1982 267 282
416. Cornell, R. G., Wolfe, R. A., and Sanders, P. G.1984. Aspartame and brain tumors: Statistical issues. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 459–479. Marcel Dekker, New York.
417. S.M. Davies J.A. Ross W.G. Woods Aspartame and Brain Tumors: Junk Food Science 1996 University of Minnesota
418. D.L. Davis A. Ahlbom D. Hoel C. Percy Is brain cancer mortality increasing in industrial countries? Am. J. Ind. Med. 19 1991 421 431
419. 1996 Annual Report of the Committees on Toxicity, Mutagenicity, and Carcinogenicity of Chemicals in Food, Consumer Products and the Environment 1998 Department of Health p. 56–57
420. Scientific Committee for Food: Minutes of the 107th meeting of the Scientific Committee for Food, June 12–13, 1997 1997 p. 9–10
421. W.G. Flamm Reply to Olney et al. “Increasing brain tumor rates: Is there a link to aspartame?” (letter) J. Neuropathol. Exp. Neurol. 56 1997 105 106
422. Fed. Regist. 46 1981 38285 38308
423. Fed. Regist. 48 1983 31376 31382
424. Fed. Regist. 49 1984 6672 6682
425. L. Tollefson letter (March 20, 1992) to H. J. Roberts regarding his article, “Does Aspartame Cause Human Brain Cancer” 1992
426. Food and Drug Administration, 1996, FDA Statement on Aspartame , FDA Talk Paper, November 18, 1996.
427. JFSSG. 1999
428. N.H. Greig L.G. Ries R. Yancik S.I. Rapoport Increasing annual incidence of primary malignant brain tumors in elderly J. Natl. Cancer Inst. 82 1990 1621 1624
429. J.G. Gurney J.M. Pogoda E.A. Holly S.S. Hecht S. Preston-Martin Aspartame consumption in relation to childhood brain tumor risk: Results from a case-control study J. Natl. Cancer Inst. 89 1997 1072 1074
430. Hardell, L, Nasman, A, Pahlson, A, and, Hallquist, A. 2000, Case-control study on radiology work, medical x-ray investigations, and use of cellular telephones as risk factors for brain tumors, Medscape Gen. Med. May 4, 2000.
431. Health and Welfare Canada, 1981, Aspartame , Information Letter No. 602, Health Protection Branch, Ottawa.
432. H. Ishii Incidence of brain tumors in rats fed aspartame Toxicol. Lett. 7 1981 433 437
433. WHO Food Additive Series No. 15 1980 JECFA Geneva p. 18–86
434. Koestner, A. 1980, Prepared Statement: Aspartame Public Board of Inquiry , February 1, 1980, FDA Docket No. 75F-0355.
435. Koestner, A.1984. Aspartame and brain tumors: Pathology issues. In Aspartame: Physiology and BiochemistryL. D. Stegink and L. J. Filer, Jr., Eds., pp. 447–457. Marcel Dekker, New York.
436. A. Koestner Reply to Olney et al. “Increasing brain tumor rates: Is there a link to aspartame?” (letter) J. Neuropathol. Exp. Neurol. 56 1997 107 109
437. Kotsonis, F. N., and Hjelle, J. J.1996. The safety assessment of aspartame: Scientific and regulatory considerations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 23–41. CRC Press, Boca Raton, FL.
438. C. La Vecchia F. Lucchini E. Negri P. Boyle P. Maisonneuve F. Levi Trends of cancer mortality in Europe, 1955–1989. IV. Urinary tract, eye, brain and nerves, and thyroid Eur. J. Cancer. 28A 1992 1210 1281
439. J.M. Legler L.A. Gloeckler Ries M.A. Smith J.L. Warren E.F. Heineman R.S. Kaplan M.S. Linet Brain and other central nervous system cancers: Recent trends in incidence and mortality J. Natl. Cancer Inst. 91 1999 1382 1390
440. P.S. Levy D. Hedeker Reply to Olney et al. “Increasing brain tumor rates: Is there a link to aspartame?” (letter) J. Neuropathol. Exp. Neurol. 55 1996 1280
441. M.S. Linet L.A.G. Ries M.A. Smith R.E. Tarone S.S. Devesa Cancer surveillance series: Recent trends in childhood cancer incidence and mortality in the United States J. Natl. Cancer Inst. 91 1999 1051 1058
442. E. Marshall Experts clash over cancer data Science 250 1990 900 902
443. I. Meier S.E. Shephard W.K. Lutz Nitrosation of aspartic acid, aspartame, and glycine ethylester: Alkylation of 4-( p -nitrobenzyl)pyridine (NBP) in vitro and binding to DNA in the rat Mutat. Res. 238 1990 193 201
444. Ministry of Agriculture Fisheries, and Food (MAFF), 1982, Food Additives and Contaminants Committee Report on the Review of Sweeteners in Food , FAC/REP/34:HMSO, 1982, Committee on Toxicity of Chemicals in Food, Consumer Products and the Environment, United Kingdom.
445. B. Modan D.K. Wagener J.J. Feldman H.M. Rosenberg M. Feinleib Increased mortality from brain tumors: A combined outcome of diagnostic technology and change of attitude toward the elderly Am. J. Epidemiol. 135 1992 1349 1357
446. C.S. Muir H.H. Storm A. Polednak Brain and other nervous system tumours Cancer Surv. 19/20 1994 369 392
447. National Cancer Institute (NCI), 1997, Cancer Facts. Artificial Sweeteners , http://cis.nci.nih.gov/fact/pdfdraft/3_risk/fs3_19.pdf .
448. National Cancer Institute (NCI), 1999, SEER Cancer Statistics Review 1973–1996 .
449. Nauta, W. J. H. 1981, Letter to FDA Commissioner Hayes, August 6, 1981.
450. J.W. Olney N.B. Farber E. Spitznagel L.N. Robins Increasing brain tumor rates: Is there a link to aspartame? J. Neuropathol. Exp. Neurol. 55 1996 1115 1123
451. H.J. Roberts Does aspartame cause human brain cancer? J. Adv. Med. 4 1991 231 241
452. J.A. Ross Brain tumors and artificial sweeteners? A lesson on not getting soured on epidemiology Med. Pediatr. Oncol. 30 1998 7 8
453. Reports of the Scientific Committee for Food, sixteenth series 1985
454. S.E. Shephard W.K. Lutz Nitrosation of dietary precursors Cancer Surv. 8 1989 401 421
455. Shephard, S. E., Meier, I., and Lutz, W.1991. Alkylating potency of nitrosated amino acids and peptides. In Relevance to Human Cancer of n-Nitroso Compounds, Tobacco Smoke, and MycotoxinsI. K. O'Neill, J. Chen, and H. Bartsch, Eds., pp. 383–387. IARC, Lyon, France.
456. S.E. Shephard K. Wakabayashi M. Nagao Mutagenic activity of peptides and the artificial sweetener aspartame after nitrosation Food Chem. Toxicol. 31 1993 323 329
457. M.A. Smith B. Freidlin L.A. Gloeckler Ries R. Simon Trends in reported incidence of primary malignant brain tumors in children in the United States J. Natl. Cancer Inst. 90 1998 1269 1277
458. J.A. Swenberg Brain tumors—Problems and perspectives Food Chem. Toxicol. 24 1986 155 158
459. U.S. General Accounting Office, 1987, Food Additive Approval Process Followed for Aspartame , Food and Drug Administration.
460. M.R. Weihrauch V. Diehl H. Bohlen Artificial sweeteners—Is there a carcinogenic risk? Medizinische Klinik. 96 2001 670 675
461. M.H. Werner S. Phuphanich G.H. Lyman The increasing incidence of malignant gliomas and primary central nervous system lymphoma in the elderly Cancer 76 1995 1634 1642
462. H.H. Butchko Reply to Walton et al. “Adverse reactions to aspartame: double-blind challenge in patients from a vulnerable population” (letter) Biol. Psychiatry 36 1994 206 207
463. H.H. Butchko F.N. Kotsonis Acceptable daily intake vs actual intake: The aspartame example J. Am. Coll. Nutr. 10 1991 258 266
464. Evaluation of Consumer Complaints Related to Aspartame Use 1984 CDC Atlanta
465. H. Curtius W. Endres N. Blau Effect of high-protein meal plus aspartame ingestion on plasma phenylalanine concentrations in obligate heterozygotes for phenylketonuria Metabolism 43 1994 413 416
466. de Sonneville, L. M. J.1999. Amsterdam neuropsychological tasks: A computer-aided assessment program. In Cognitive Ergonomics, Clinical Assessment and Computer-Assisted Learning: Computers in PsychologyB. P. L. M. Den Brinker, P. J. Beek, A. N. Brand, S. J. Maarse, and L. J. M. Mulder, Eds., Vol. 6, pp. 187–203. Swets & Zeitlinger, Lisse, The Netherlands.
467. Elsas, L. J., and Trotter, J. F.1988. Changes in physiological concentrations of blood phenylalanine produce changes in sensitive parameters of human brain function. In Dietary Phenylalanine and Brain FunctionR. J. Wurtman and E. Ritter-Walker, Eds., pp. 187–195. Birkhauser, Boston.
468. C.M. Epstein J.F. Trotter A. Averbook S. Freeman M.H. Kutner L.J. Elsas EEG mean frequencies are sensitive indices of phenylalanine effects on normal brain Electroencephalogr. Clin. Neurophysiol. 72 1989 133 139
469. J.W. Gerrard J.S. Richardson J. Donat Neuropharmacological evaluation of movement disorders that are adverse reactions to specific foods Int. J. Neurosci. 76 1994 61 69
470. A.J. Gulya R.B. Sessions T.R. Troost Aspartame and dizziness: preliminary results of a prospective, nonblinded, prevalence and attempted cross-over study Am. J. Otol. 13 1992 438 442
471. V. Gupta C. Cochran T.F. Parker D.L. Long J. Ashby M.A. Gorman G.U. Liepa Effect of aspartame on plasma amino acid profiles of diabetic patients with chronic renal failure Am. J. Clin. Nutr. 49 1989 1302 1306
472. Z.I. Hertelendy C.I. Mendenhall S.D. Rouster L. Marshall R. Weesner Biochemical and clinical effects of aspartame in patients with chronic, stable alcoholic liver disease Am. J. Gastroenterol. 88 1993 737 743
473. S.C.J. Huijbregts L.M.J. de Sonneville R. Licht F.J. van Spronsen P.H. Verkerk J.A. Sergeant Sustained attention and inhibition of cognitive interference in treated phenylketonuria: Associations with concurrent and lifetime phenylalanine concentrations Neuropsychologia 40 2002 7 15
474. P.J. Karstaedt J.H. Pincus Aspartame use in Parkinson's disease Neurology 43 1993 611 613
475. R. Koch K.N.F. Shaw M. Williamson M. Haber Use of aspartame in phenylketonuric heterozygous adults J. Toxicol. Environ. Health 2 1976 453 457
476. E. Schmidt A. Rupp P. Burgard J. Pietz J. Weglage L. De Sonneville Sustained attention in adult phenylketonuria: The influence of the concurrent phenylalanine blood level J. Clin. Exp. Neuropsychol. 16 1994 681 688
477. Schomer, D. L., Spiers, P., and Sabounjian, L. A.1996. Evaluation of behavior, cognition, mood, and electroencephalograms in normal adults and potentially vulnerable populations. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 217–233. CRC Press, Boca Raton, FL.
478. Scriver, C. R., and Kaufman, S.2001. Hyperphenylalaninemia: Phenylalanine hydroxylase. In The Metabolic and Molecular Bases of Inherited DiseaseC. R. Scriver, A. Beaudet, W. S. Sly, and D. Valle, Eds., eighth ed., Vol. II, pp. 667–1724. McGraw–Hill, New York.
479. Stegink, L. D., and Filer, L. J. Jr.1996. Effects of aspartame ingestion of plasma aspartate, phenylalanine, and methanol concentrations in potentially sensitive populations. In The Clinical Evaluation of A Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 87–113. CRC Press, Boca Raton, FL.
480. L.D. Stegink L.J. Filer Jr. G.L. Baker J.E. McDonnell Effect of aspartame loading upon plasma and erythrocyte amino acid levels in phenylketonuric heterozygotes and normal adult subjects J. Nutr. 109 1979 708 717
481. L.D. Stegink L.J. Filer Jr. G.L. Baker J.E. McDonnell Effect of an abuse dose of aspartame upon plasma and erythrocyte levels of amino acids in phenylketonuric heterozygous and normal adults J. Nutr. 110 1980 2216 2224
482. L.D. Stegink L.C. Wolf-Novak L.J. Filer Jr. E.F. Bell E.E. Ziegler W.L. Krause M.C. Brummel Aspartame-sweetened beverage: Effect on plasma amino acid concentrations in normal adults and adults heterozygous for phenylketonuria J. Nutr. 117 1987 1989 1995
483. L.D. Stegink L.J. Filer Jr. G.L. Baker E.F. Bell E.E. Ziegler M.C. Brummel W.L. Krause Repeated ingestion of aspartame-sweetened beverage: effect on plasma amino acid concentrations in individuals heterozygous for phenylketonuria Metabolism 38 1989 78 84
484. L.D. Stegink L.J. Filer Jr. E.F. Bell E.E. Ziegler T.R. Tephly W.L. Krause Repeated ingestion of aspartame-sweetened beverages: Further observations in individuals heterozygous for phenylketonuria Metabolism 39 1990 1076 1081
485. L.D. Stegink L.J. Filer Jr. M.C. Brummel G.L. Baker W.L. Krause E.F. Bell E.E. Ziegler Plasma amino acid concentrations and amino acid ratios in normal adults and adults heterozygous for phenylketonuria ingesting a hamburger and milk shake meal Am. J. Clin. Nutr. 53 1991 670 675
486. F. Trefz L. de Sonneville P. Matthis C. Benninger B. Lanz-Englert H. Bickel Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine) Hum. Genet. 93 1994 369 374
487. C. Tschanz H.H. Butchko W.W. Stargel F.N. Kotsonis Eds The Clinical Evaluation of A Food Additive: Assessment of Aspartame 1996 CRC Press Boca Raton
488. R.G. Walton R. Hudak R.J. Green-Waite Adverse reactions to aspartame: Double-blind challenge in patients from a vulnerable population Biol. Psychiatry 34 1993 13 17
489. L. Abdallah M. Chabert J. Louis-Sylvestre Cephalic phase responses to sweet taste Am. J. Clin. Nutr. 65 1997 737 743
490. Diabetes Care 25 2002 S50 S60
491. H.E. Carlson J.H. Shah Aspartame and its constituent amino acids: Effects on prolactin, cortisol, growth hormone, insulin, and glucose in normal humans Am. J. Clin. Nutr. 49 1989 427 432
492. S. Colagiuri J.J. Miller R.A. Edwards Metabolic effects of adding sucrose and aspartame to the diet of subjects with noninsulin-dependent diabetes mellitus Am. J. Clin. Nutr. 50 1989 474 478
493. B. Härtel H.-J. Graubaum B. Schneider Effect of sweetener solutions on insulin secretion and blood glucose level Ernahrungs-Umschau 40 1993 152 155
494. D.L. Horwitz M. McLane P. Kobe Response to single dose of aspartame or saccharin by NIDDM patients Diabetes Care 11 1988 230 234
495. A.S. Leon D.B. Hunninghake C. Bell D.K. Rassin T.R. Tephly Safety of long-term large doses of aspartame Arch. Intern. Med. 149 1989 2318 2324
496. A. Leon Comment on effect of large doses of aspartame on urinary calcium excretion (reply to Nguyen et al. ) J. Clin. Endocrin. Metab. 84 1999 383 384
497. W.J. Malaisse A. Vanonderbergen K. Louchami H. Jijakli F. Malaisse-Lagae Effects of artificial sweeteners on insulin release and cationic fluxes in rat pancreatic islets Cell. Signal. 10 1998 727 733
498. K.J. Melanson M.S. Westerterp-Plantenga L.A. Campfield W.H.M. Saris Blood glucose and meal patterns in time-blinded males, after aspartame, carbohydrate, and fat consumption, in relation to sweetness perception Br. J. Nutr. 82 1999 437 446
499. J.C. Melchior D. Rigaud N. Colas-Linhart A. Petiet A. Girard M. Apfelbaum Immunoreactive beta-endorphin increases after an aspartame chocolate drink in healthy human subjects Physiol. Behav. 50 1991 941 944
500. S.E. Møller Effect of aspartame and protein, administered in phenylalanine-equivalent doses, on plasma neutral amino acids, aspartate, insulin and glucose in man Pharmacol. Toxicol. 68 1991 408 412
501. J.K. Nehrling P. Kobe M.P. McLane R.E. Olson S. Kamath D.L. Horwitz Aspartame use by persons with diabetes Diabetes Care 8 1985 415 417
502. U.N. Nguyen G. Dumoulin M. Henriet J. Regnard Aspartame ingestion increases urinary calcium but not oxalate excretion in healthy subjects J. Clin. Endocrin. Metab. 83 1998 165 168
503. G. Okuno F. Kawakami H. Tako T. Kashikara S. Shibamoto T. Yamazaki K. Yamamoto M. Saeki Glucose tolerance, blood lipid, insulin and glucagon concentration after single or continuous administration of aspartame in diabetics Diabetes Res. Clin. Pract. 2 1986 23 27
504. J. Overduin A. Jansen Conditioned insulin and blood sugar responses in humans in relation to binge eating Physiol. Behav. 61 1997 569 575
505. P.J. Rogers J. Carlyle A.J. Hill J.E. Blundell Uncoupling sweet taste and calories: comparison of the effects of glucose and the three intense sweeteners on hunger and food intake Physiol. Behav. 43 1988 547 552
506. H. Shigeta T. Yoshida M. Nakai H. Mori Y. Kano H. Nishioka S. Kajiyama Y. Kitagawa T. Kanatsuna M. Kondo K. Otsuki Effects of aspartame on diabetic rats and diabetic patients J. Nutr. Sci. Vitaminol. 31 1985 533 540
507. L.D. Stegink M.C. Brummel T.J. Persoon L.J. Filer Jr. E.F. Bell E.E. Zeigler Effect of sucrose on the metabolic disposition of aspartame Am. J. Clin. Nutr. 52 1990 335 341
508. S.B. Stern S.J. Bleicher A. Flores G. Gombos D. Recitas J. Shu Administration of aspartame in non-insulin dependent diabetics J. Toxicol. Environ. Health 2 1976 429 439
509. S. Tamura W. Inoue H. Kanashige H. Sakai Experience on the use of aspartame for a long period in diabetic patients Rinsho Eiyo (Clin. Nutr.) 64 1984 515 516
510. K.L. Teff J. Devine K. Engelman Sweet taste: Effect on cephalic phase insulin release in men Physiol. Behav. 57 1995 1089 1095
511. B.J. Tepper L.M. Hartfiel S.H. Schneider Sweet taste and diet in type II diabetes Physiol. Behav. 60 1996 13 18
512. L.C. Wolf-Novak L.D. Stegink M.C. Brummel T.J. Persoon L.J. Filer Jr. E.F. Bell E.E. Ziegler W.L. Krause Aspartame ingestion with and without carbohydrate in phenylketonuric and normal subjects: effect on plasma concentrations of amino acids, glucose, and insulin Metabolism 39 1990 391 396
513. D. Wouassi J. Mercier S. Ahmaidi J.F. Brun B. Mercier A. Orsetti C. Préfaut Metabolic and hormonal responses during repeated bouts of brief and intense exercise: Effects of pre-exercise glucose ingestion Eur. J. Appl. Physiol. 76 1997 197 202
514. G.H. Anderson S. Saravis R. Schacher S. Zlotkin L.A. Leiter Aspartame: Effect on lunch-time food intake, appetite and hedonic response in children Appetite 13 1989 93 103
515. J.W. Anderson E.C. Konz R.C. Frederich C.L. Wood Long-term weight-loss maintenance: A meta-analysis of US studies Am. J. Clin. Nutr. 74 2001 579 584
516. A. Astrup A. Raben T.H. Vasilaras A.C. Møller Sucrose in soft drinks is fattening: A randomized 10 week study in overweight subjects Am. J. Clin. Nutr. 75 2002 405S
517. C.E. Begley Government should strengthen regulation in the weight loss industry J. Am. Diet. Assoc. 91 1991 1255 1257
518. L.L. Birch L. McPhee S. Sullivan Children's food intake following drinks sweetened with sucrose or aspartame: Time course effects Physiol. Behav. 45 1989 387 395
519. R.M. Black P. Tanaka L.A. Leiter G.H. Anderson Soft drinks with aspartame: Effect on subjective hunger, food selection, and food intake of young adult males Physiol. Behav. 49 1991 803 810
520. R.M. Black L.A. Leiter G.H. Anderson Consuming aspartame with and without taste: Differential effects on appetite and food intake of young adult males Physiol. Behav. 53 1993 459 466
521. G.L. Blackburn B.S. Kanders Medical evaluation and treatment of the obese patient with cardiovascular disease Am. J. Cardiol. 60 1987 55G 58G
522. G.L. Blackburn B.S. Kanders P.T. Lavin S.D. Keller J. Whatley The effect of aspartame as part of a multidisciplinary weight-control program on short- and long-term control of body weight Am. J. Clin. Nutr. 65 1997 409 418
523. Blackburn, G. L.1999. Sweeteners and weight control. In Low-Calorie Sweeteners: Present and FutureA. Corti, Ed., pp. 77–87. Karger, Basel.
524. G.L. Blackburn The public health implications of the dietary approaches to stop hypertension trial Am. J. Clin. Nutr. 74 2001 1 2
525. J.E. Blundell A.J. Hill Paradoxical effects of an intense sweetener (aspartame) on appetite Lancet 1 1986 1092 1093
526. Blundell, J. E., and Hill, A. J.1987. Artificial sweeteners and the control of appetite. In Implications for the Eating Disorders in Future of Predictive Safety EvaluationA. N. Worden, D. V. Parke, and J. Marks, Eds., pp. 263–281. MTP Press, Boston.
527. D.J. Canty M.M. Chan Effects of consumption of caloric vs noncaloric sweet drinks on indices of hunger and food consumption in normal adults Am. J. Clin. Nutr. 53 1991 1159 1164
528. A. Drewnowski Intense sweeteners and the control of appetite Nutr. Rev. 53 1995 1 7
529. A. Drewnowski C. Massien J. Louis-Sylvestre J. Fricker D. Chapelot M. Apfelbaum Comparing the effects of aspartame and sucrose on motivational ratings, taste preferences, and energy intakes in humans Am. J. Clin. Nutr. 59 1994 338 345
530. A. Drewnowski C. Massien J. Louis-Sylvestre J. Fricker D. Chapelot M. Apfelbaum The effects of aspartame versus sucrose on motivational ratings, taste preferences, and energy intakes in obese and lean women Int. J. Obesity 18 1994 570 578
531. Hoffman, R. 1972, Short Term Tolerance of Aspartame by Obese Adults , research report submitted by, G. D. Searle, and Co. to the Food and Drug Administration (E-24).
532. Hoffman, R. 1973, Long Term Tolerance of Aspartame by Obese Adults , research report submitted by, G. D. Searle, and Co. to the Food and Drug Administration (E-64).
533. J. Horm K. Anderson Who in America is trying to lose weight? Ann. Intern. Med. 119 1993 672 676
534. P.T. James R. Leach E. Kalamara M. Shayegli The world wide obesity epidemic Obes. Res. 9 2001 228S 233S
535. Kanders, B. S., and Blackburn, G. L.1992. Reducing primary risk factors by therapeutic weight loss. In The Treatment of the Seriously Obese PatientT. A. Wadden and T. B. Van Itallie, Eds., pp. 213–230. Guilford, New York.
536. Kanders, B. S., Blackburn, G. L., Lavin, P. T., and Kienholz, M.1996. Evaluation of weight control. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 289–299. CRC Press, Boca Raton, FL.
537. B.S. Kanders P.T. Lavin M.B. Kowalchuk I. Greenberg G.L. Blackburn An evaluation of the effect of aspartame on weight loss Appetite 11 1988 73 84
538. L. Khaodhiar G.L. Blackburn Obesity assessment Am. Heart J. 42 2001 1095 1101
539. R.H. Knopp K. Brandt R.A. Arky Effects of aspartame in young persons during weight reduction J. Toxicol. Environ. Health 2 1976 417 428
540. P.T. Lavin P.G. Sanders M.A. Mackey F.N. Kotsonis Intense sweeteners use and weight change among women: A critique of the Stellman and Garfinkel study J. Am. Coll. Nutr. 13 1994 102 105
541. R. Mattes Effects of aspartame and sucrose on hunger and energy intake in humans Physiol. Behav. 47 1990 1037 1044
542. K.P. Porikos F.X. Pi-Sunyer Regulation of food intake in human obesity: Studies with caloric dilution and exercise Clin. Endocrinol. Metab. 13 1984 547 561
543. K.P. Porikos G. Booth T.B. Van Itallie Effect of covert nutritive dilution on the spontaneous intake of obese individuals: A pilot study Am. J. Clin. Nutr. 30 1977 1638 1644
544. K.P. Porikos M.F. Hesser T.B. Van Itallie Caloric regulation in normal weight men maintained on a palatable diet of conventional foods Physiol. Behav. 29 1982 293 300
545. A.G. Renwick Intense sweeteners, food intake, and the weight of a body of evidence Physiol. Behav. 55 1994 139 143
546. J.I. Robinson S.L. Hoerr J. Strandmark B. Mavis Obesity, weight loss and health J. Am. Diet. Assoc. 93 1993 445 449
547. J. Rodin Comparative effects of fructose, aspartame, glucose, and water preloads on calorie and macronutrient intake Am. J. Clin. Nutr. 51 1990 428 435
548. P.J. Rogers J. Carlyle A.J. Hill J.E. Blundell Uncoupling sweet taste and calories: Comparison of the effects of glucose and three intense sweeteners on hunger and food intake Physiol. Behav. 43 1988 547 552
549. P.J. Rogers H.C. Fleming J.E. Blundell Aspartame ingested without tasting inhibits hunger and food intake Physiol. Behav. 47 1990 1239 1243
550. B.J. Rolls Effects of intense sweeteners on hunger, food intake, and body weight: A review Am. J. Clin. Nutr. 53 1991 872 878
551. Rolls, B. J., and Shide, D. J.1996. Evaluation of hunger, food intake, and body weight. In The Clinical Evaluation of a Food Additive: Assessment of AspartameC. Tschanz, H. H. Butchko, W. W. Stargel, and F. N. Kotsonis, Eds., pp. 275–287. CRC Press, Boca Raton, FL.
552. B.J. Rolls S. Kim I.C. Fedoroff Effects of drinks sweetened with sucrose or aspartame on hunger, thirst and food intake in men Physiol. Behav. 48 1990 19 26
553. B.J. Rolls L.J. Laster A. Summerfelt Hunger and food intake following consumption of low-calorie foods Appetite 13 1989 115 127
554. S.D. Stellman L. Garfinkel Artificial sweetener use and one-year weight change among women Prev. Med. 15 1986 195 202
555. S.D. Stellman L. Garfinkel Patterns of artificial sweetener use and weight change in an American Cancer Society prospective study Appetite 11 1988 85 91
556. M.G. Tordoff A.M. Alleva Effect of drinking soda sweetened with aspartame or high-fructose corn syrup on food intake and body weight Am. J. Clin. Nutr. 51 1990 963 969
557. U.S. Department of Health and Human Services. 2001, The Surgeon General's Call to Action to Prevent and Decrease Overweight and Obesity , U.S. Department of Health and Human Services, Public Health Service, Office of the Surgeon General, Rockville, MD. [Available from, U.S. GPO, Washington, DC, ]
558. T.A. Wadden Treatment of obesity by moderate and severe caloric restriction: Results of clinical research trials Ann. Intern. Med. 119 1993 688 693
559. J.F. Wilson Lunch eating behavior of preschool children: Effects of age, gender, and type of beverage served Physiol. Behav. 70 2000 27 33
560. World Health Organization (WHO). 2000, Obesity: Preventing and Managing the Global Epidemic , WHO Obesity Technical Report Series 894, WHO, Geneva.